{
    "id": "dbpedia_2417_0",
    "rank": 95,
    "data": {
        "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC172945/",
        "read_more_link": "",
        "language": "en",
        "title": "Infections in solid-organ transplant recipients.",
        "top_image": "https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0",
        "meta_img": "https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0",
        "images": [
            "https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png",
            "https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg",
            "https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg",
            "https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg",
            "https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/logo-cmr.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "R Patel",
            "C V Paya"
        ],
        "publish_date": "1997-01-12T00:00:00",
        "summary": "",
        "meta_description": "Solid-organ transplantation is a therapeutic option for many human diseases. Infections are a major complication of solid-organ transplantation. All candidates should undergo a thorough infectious-disease screening prior to transplantation. There are ...",
        "meta_lang": "en",
        "meta_favicon": "https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico",
        "meta_site_name": "PubMed Central (PMC)",
        "canonical_link": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC172945/",
        "text": "Clin Microbiol Rev. 1997 Jan; 10(1): 86–124.\n\nPMCID: PMC172945\n\nPMID: 8993860\n\nInfections in solid-organ transplant recipients.\n\nDivision of Infectious Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.\n\nAbstract\n\nSolid-organ transplantation is a therapeutic option for many human diseases. Infections are a major complication of solid-organ transplantation. All candidates should undergo a thorough infectious-disease screening prior to transplantation. There are three time frames, influenced by surgical factors, the level of immunosuppression, and environmental exposures, during which infections of specific types most frequently occur posttransplantation. Most infections during the first month are related to surgical complications. Opportunistic infections typically occur from the second to the sixth month. During the late posttransplant period (beyond 6 months), transplantation recipients suffer from the same infections seen in the general community. Opportunistic bacterial infections seen in transplant recipients include those caused by Legionella spp., Nocardia spp., Salmonella spp., and Listeria monocytogenes. Cytomegalovirus is the most common cause of viral infections. Herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and others are also significant pathogens. Fungal infections, caused by both yeasts and mycelial fungi, are associated with the highest mortality rates. Mycobacterial, pneumocystis, and parasitic diseases may also occur.\n\nFull Text\n\nThe Full Text of this article is available as a PDF (564K).\n\nSelected References\n\nThese references are in PubMed. This may not be the complete list of references from this article.\n\nAbbott MR, Smith DD. Mycobacterial infections in immunosuppressed patients. Med J Aust. 1981 Apr 4;1(7):351–353. [PubMed] [Google Scholar]\n\nAbu-Farsakh H, Cagle PT, Buffone GJ, Bruner JM, Weilbaecher D, Greenberg SD. Heart allograft involvement with Epstein-Barr virus-associated posttransplant lymphoproliferative disorder. Arch Pathol Lab Med. 1992 Jan;116(1):93–95. [PubMed] [Google Scholar]\n\nAgarwal A, Gupta A, Sakhuja V, Talwar P, Joshi K, Chugh KS. Retinitis following disseminated cryptococcosis in a renal allograft recipient. Efficacy of oral fluconazole. Acta Ophthalmol (Copenh) 1991 Jun;69(3):402–405. [PubMed] [Google Scholar]\n\nAjello L, Georg LK, Steigbigel RT, Wang CJ. A case of phaeohyphomycosis caused by a new species of Phialophora. Mycologia. 1974 May-Jun;66(3):490–498. [PubMed] [Google Scholar]\n\nAlbes J, Haverich A, Freihorst J, von der Hardt H, Manthey-Stiers F. Management of mycotic rupture of the ascending aorta after heart-lung transplantation. Ann Thorac Surg. 1990 Dec;50(6):982–983. [PubMed] [Google Scholar]\n\nAldape KD, Fox HS, Roberts JP, Ascher NL, Lake JR, Rowley HA. Cladosporium trichoides cerebral phaeohyphomycosis in a liver transplant recipient. Report of a case. Am J Clin Pathol. 1991 Apr;95(4):499–502. [PubMed] [Google Scholar]\n\nAlexander JA, Brouillette DE, Chien MC, Yoo YK, Tarter RE, Gavaler JS, Van Thiel DH. Infectious esophagitis following liver and renal transplantation. Dig Dis Sci. 1988 Sep;33(9):1121–1126. [PubMed] [Google Scholar]\n\nAlgan M, Jonon B, George JL, Lion C, Kessler M, Burdin JC. Listeria monocytogenes endophthalmitis in a renal-transplant patient receiving ciclosporin. Ophthalmologica. 1990;201(1):23–27. [PubMed] [Google Scholar]\n\nAllen KA, Markin RS, Rennard SI, Shaw BW, Jr, Thompson AB, Wood RP, Woods GS, Linder J. Bronchoalveolar lavage in liver transplant patients. Acta Cytol. 1989 Jul-Aug;33(4):539–543. [PubMed] [Google Scholar]\n\nAlsip SG, Cobbs CG. Pseudallescheria boydii infection of the central nervous system in a cardiac transplant recipient. South Med J. 1986 Mar;79(3):383–384. [PubMed] [Google Scholar]\n\nal-Sulaiman MH, Dhar JM, al-Hasani MK, Haleem A, al-Khader A. Tuberculous interstitial nephritis after kidney transplantation. Transplantation. 1990 Jul;50(1):162–164. [PubMed] [Google Scholar]\n\nAmpel NM, Wing EJ. Legionella infection in transplant patients. Semin Respir Infect. 1990 Mar;5(1):30–37. [PubMed] [Google Scholar]\n\nAnandi V, John TJ, Walter A, Shastry JC, Lalitha MK, Padhye AA, Ajello L, Chandler FW. Cerebral phaeohyphomycosis caused by Chaetomium globosum in a renal transplant recipient. J Clin Microbiol. 1989 Oct;27(10):2226–2229. [PMC free article] [PubMed] [Google Scholar]\n\nAnderson DJ, Schmidt C, Goodman J, Pomeroy C. Cryptococcal disease presenting as cellulitis. Clin Infect Dis. 1992 Mar;14(3):666–672. [PubMed] [Google Scholar]\n\nAndrews W, Fyock B, Gray S, Coln D, Hendrickse W, Siegel J, Belknap B, Hogge A, Benser M, Kennard B, et al. Pediatric liver transplantation: the Dallas experience. Transplant Proc. 1987 Aug;19(4):3267–3276. [PubMed] [Google Scholar]\n\nArduino RC, Johnson PC, Miranda AG. Nocardiosis in renal transplant recipients undergoing immunosuppression with cyclosporine. Clin Infect Dis. 1993 Apr;16(4):505–512. [PubMed] [Google Scholar]\n\nArmes JE, Angus P, Southey MC, Battaglia SE, Ross BC, Jones RM, Venter DJ. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation. Cancer. 1994 Nov 1;74(9):2436–2441. [PubMed] [Google Scholar]\n\nArnold JC, Nouri-Aria KT, O'Grady JG, Portmann BC, Alexander GJ, Williams R. Hepatic alpha-interferon expression in cytomegalovirus-infected liver allograft recipients with and without vanishing bile duct syndrome. Clin Investig. 1993 Mar;71(3):191–196. [PubMed] [Google Scholar]\n\nArnold JC, Portmann BC, O'Grady JG, Naoumov NV, Alexander GJ, Williams R. Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome. Hepatology. 1992 Aug;16(2):285–292. [PubMed] [Google Scholar]\n\nArnouts PJ, Ramael MR, Ysebaert DK, Verpooten GA, de Broe ME, van Marck EA, Pattyn SR. Legionella pneumophila peritonitis in a kidney transplant patient. Scand J Infect Dis. 1991;23(1):119–122. [PubMed] [Google Scholar]\n\nArnow PM, Andersen RL, Mainous PD, Smith EJ. Pumonary aspergillosis during hospital renovation. Am Rev Respir Dis. 1978 Jul;118(1):49–53. [PubMed] [Google Scholar]\n\nAscher NL, Simmons RL, Marker S, Klugman J, Najarian JS. Tuberculous joint disease in transplant patients. Am J Surg. 1978 Jun;135(6):853–856. [PubMed] [Google Scholar]\n\nAscher NL, Simmons RL, Marker S, Najarian JS. Listeria infection in transplant patients. Five cases and a review of the literature. Arch Surg. 1978 Jan;113(1):90–94. [PubMed] [Google Scholar]\n\nAvery RK. Infections and immunizations in organ transplant recipients: a preventive approach. Cleve Clin J Med. 1994 Sep-Oct;61(5):386–392. [PubMed] [Google Scholar]\n\nAzadian BS, Beck A, Curtis JR, Cherrington LE, Gower PE, Phillips M, Eastwood JB, Nicholls J. Disseminated infection with mycobacterium chelonei in a haemodialysis patient. Tubercle. 1981 Dec;62(4):281–284. [PubMed] [Google Scholar]\n\nBach MC, Adler JL, Breman J, P'eng FK, Sahyoun A, Schlesinger RM, Madras P, Monaco AP. Influence of rejection therapy on fungal and nocardial infections in renal-transplant recipients. Lancet. 1973 Jan 27;1(7796):180–184. [PubMed] [Google Scholar]\n\nBadger IL, Crosby HA, Kong KL, Baker JP, Hutchings P, Elliott TS, McMaster P, Bion JF, Buckels JA. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplant Proc. 1991 Feb;23(1 Pt 2):1460–1461. [PubMed] [Google Scholar]\n\nBailey TC, Ettinger NA, Storch GA, Trulock EP, Hanto DW, Dunagan WC, Jendrisak MD, McCullough CS, Kenzora JL, Powderly WG. Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants. Am J Med. 1993 Sep;95(3):273–278. [PubMed] [Google Scholar]\n\nBalfour HH, Jr, Chace BA, Stapleton JT, Simmons RL, Fryd DS. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med. 1989 May 25;320(21):1381–1387. [PubMed] [Google Scholar]\n\nBalfour HH, Jr, Sachs GW, Welo P, Gehrz RC, Simmons RL, Najarian JS. Cytomegalovirus vaccine in renal transplant candidates: progress report of a randomized, placebo-controlled, double-blind trial. Birth Defects Orig Artic Ser. 1984;20(1):289–304. [PubMed] [Google Scholar]\n\nWeinberg JM. Issues in the pathophysiology of nephrotoxic renal tubular cell injury pertinent to understanding cyclosporine nephrotoxicity. Transplant Proc. 1985 Aug;17(4 Suppl 1):81–90. [PubMed] [Google Scholar]\n\nBalk AH, Weimar W, Rothbarth PH, Meeter K, Metselaar HJ, Mochtar B, Simoons ML. Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience. Infection. 1993 Jul-Aug;21(4):195–200. [PubMed] [Google Scholar]\n\nBallardie FW, Winearls CG, Williams G. Cyclosporin and steroids in renal transplantation: risk of Pneumocystis carinii pneumonia? Lancet. 1984 Sep 15;2(8403):638–639. [PubMed] [Google Scholar]\n\nBarbara JA, Clarkson AR, LaBrooy J, McNeil JD, Woodroffe AJ. Candida albicans arthritis in a renal allograft recipient with an interaction between cyclosporin and fluconazole. Nephrol Dial Transplant. 1993;8(3):263–266. [PubMed] [Google Scholar]\n\nBaringer JR, Swoveland P. Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med. 1973 Mar 29;288(13):648–650. [PubMed] [Google Scholar]\n\nBarkholt L, Ericzon BG, Tollemar J, Malmborg AS, Ehrnst A, Wilczek H, Andersson J. Infections in human liver recipients: different patterns early and late after transplantation. Transpl Int. 1993 Mar;6(2):77–84. [PubMed] [Google Scholar]\n\nBarkholt LM, Ericzon BG, Ehrnst A, Forsgren M, Andersson JP. Cytomegalovirus infections in liver transplant patients: incidence and outcome. Transplant Proc. 1990 Feb;22(1):235–237. [PubMed] [Google Scholar]\n\nBarton IK, Nicholson F. Use of pooled immunoglobulin and acyclovir as prophylaxis against cytomegalovirus disease in recipients of renal allografts. Nephrol Dial Transplant. 1991;6(7):525–526. [PubMed] [Google Scholar]\n\nBasadonna G, Feria A, Perez R, Klein H, Sturges M, Colquhoun S. Incidence of infection and acute rejection after cytomegalovirus immune globulin prophylaxis in renal transplantation. Transplant Proc. 1994 Oct;26(5 Suppl 1):52–53. [PubMed] [Google Scholar]\n\nBasgoz N, Preiksaitis JK. Post-transplant lymphoproliferative disorder. Infect Dis Clin North Am. 1995 Dec;9(4):901–923. [PubMed] [Google Scholar]\n\nBauling PC, Weil R, 3rd, Schröter GP. Legionella lung abscess after renal transplantation. J Infect. 1985 Jul;11(1):51–55. [PubMed] [Google Scholar]\n\nBell R, Sheil AG, McDonald JA, McCaughan GW. The role of CMV immune prophylaxis in patients at risk of primary CMV infection following orthotopic liver transplantation. Transplant Proc. 1989 Oct;21(5):3781–3782. [PubMed] [Google Scholar]\n\nBell TJ, Williams GB. Successful treatment of tuberculosis in renal transplant recipients. J R Soc Med. 1978 Apr;71(4):265–268. [PMC free article] [PubMed] [Google Scholar]\n\nBenedict LM, Kusne S, Torre-Cisneros J, Hunt SJ. Primary cutaneous fungal infection after solid-organ transplantation: report of five cases and review. Clin Infect Dis. 1992 Jul;15(1):17–21. [PubMed] [Google Scholar]\n\nBen Hamida F, Achard JM, Westeel PF, Chandenier J, Bouzernidj M, Petit J, Carme B, Fournier A. Leg granuloma due to Neocosmospora vasinfecta in a renal graft recipient. Transplant Proc. 1993 Jun;25(3):2292–2292. [PubMed] [Google Scholar]\n\nBen Hamida M, Bedrossian J, Pruna A, Fouqueray B, Metivier F, Idatte JM. Fungal mycotic aneurysms and visceral infection due to Scedosporium apiospermum in a kidney transplant patient. Transplant Proc. 1993 Jun;25(3):2290–2291. [PubMed] [Google Scholar]\n\nBensousan T, Garo B, Islam S, Bourbigot B, Cledes J, Garre M. Possible transfer of Pneumocystis carinii between kidney transplant recipients. Lancet. 1990 Oct 27;336(8722):1066–1067. [PubMed] [Google Scholar]\n\nBerenguer J, Prieto M, Mir J, Cordoba J, Rayón M. Hepatitis C viral infection after orthotopic liver transplantation. Adv Exp Med Biol. 1994;368:173–179. [PubMed] [Google Scholar]\n\nBerk MR, Meyers AM, Cassal W, Botha JR, Myburgh JA. Non-typhoid salmonella infections after renal transplantation. A serious clinical problem. Nephron. 1984;37(3):186–189. [PubMed] [Google Scholar]\n\nBibashi E, Papagianni A, Kelesidis A, Antoniadou R, Papadimitriou M. Peritonitis due to Aspergillus niger in a patient on continuous ambulatory peritoneal dialysis shortly after kidney graft rejection. Nephrol Dial Transplant. 1993;8(2):185–187. [PubMed] [Google Scholar]\n\nBisbe J, Vilardell J, Valls M, Moreno A, Brancos M, Andreu J. Transient fungemia and Candida arthritis due to Candida zeylanoides. Eur J Clin Microbiol. 1987 Dec;6(6):668–669. [PubMed] [Google Scholar]\n\nBjøro K, Frøland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med. 1994 Dec 15;331(24):1607–1611. [PubMed] [Google Scholar]\n\nBlitzer A, Lawson W, Meyers BR, Biller HF. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope. 1980 Apr;90(4):635–648. [PubMed] [Google Scholar]\n\nBlohmé I, Nyberg G, Jeansson S, Svalander C. Adenovirus infection in a renal transplant patient. Transplant Proc. 1992 Feb;24(1):295–295. [PubMed] [Google Scholar]\n\nBocchi EA, Bellotti G, Uip D, Kalil J, de Lourdes Higuchi M, Fiorelli A, Stolf N, Jatene A, Pilleggi F. Long-term follow-up after heart transplantation in Chagas' disease. Transplant Proc. 1993 Feb;25(1 Pt 2):1329–1330. [PubMed] [Google Scholar]\n\nBodey GP, Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis. 1989 May;8(5):413–437. [PubMed] [Google Scholar]\n\nBogers AJ, van't Wout JW, Cats VM, Quaegebeur JM, Huysmans HA. Mediastinal rupture of a thoracoabdominal mycotic aneurysm caused by Salmonella typhimurium in an immunocompromised patient. Eur J Cardiothorac Surg. 1987;1(2):116–118. [PubMed] [Google Scholar]\n\nBoivin G, Erice A, Crane DD, Dunn DL, Balfour HH., Jr Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis. Antimicrob Agents Chemother. 1993 Feb;37(2):357–359. [PMC free article] [PubMed] [Google Scholar]\n\nBolivar R, Satterwhite TK, Floyd M. Cutaneous lesions due to Mycobacterium kansasii. Arch Dermatol. 1980 Feb;116(2):207–208. [PubMed] [Google Scholar]\n\nBoon AP, Adams DH, Buckels J, McMaster P. Cerebral aspergillosis in liver transplantation. J Clin Pathol. 1990 Feb;43(2):114–118. [PMC free article] [PubMed] [Google Scholar]\n\nBoon AP, O'Brien D, Adams DH. 10 year review of invasive aspergillosis detected at necropsy. J Clin Pathol. 1991 Jun;44(6):452–454. [PMC free article] [PubMed] [Google Scholar]\n\nBortolussi RA, MacDonald MR, Bannatyne RM, Arbus GS. Treatment of Candida peritonitis by peritoneal lavage with amphotericin B. J Pediatr. 1975 Dec;87(6 Pt 1):987–988. [PubMed] [Google Scholar]\n\nBoudreaux JP, Hayes DH, Mizrahi S, Maggiore P, Blazek J, Dick D. Decreasing incidence of serious cytomegalovirus infection using gancyclovir prophylaxis in pediatric liver transplant patients. Transplant Proc. 1993 Apr;25(2):1872–1872. [PubMed] [Google Scholar]\n\nBourlond A, Alexandre G. Dermal alternariasis in a kidney transplant recipient. Dermatologica. 1984;168(3):152–156. [PubMed] [Google Scholar]\n\nBouscarat F, Samuel D, Simon F, Debat P, Bismuth H, Saimot AG. An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1. Clin Infect Dis. 1994 Nov;19(5):854–859. [PubMed] [Google Scholar]\n\nBowen PA, 2nd, Lobel SA, Caruana RJ, Leffell MS, House MA, Rissing JP, Humphries AL. Transmission of human immunodeficiency virus (HIV) by transplantation: clinical aspects and time course analysis of viral antigenemia and antibody production. Ann Intern Med. 1988 Jan;108(1):46–48. [PubMed] [Google Scholar]\n\nBoyle EM, Jr, Burdine J, Bolman RM., 3rd Successful treatment of Mycoplasma mediastinitis after heart-lung transplantation. J Heart Lung Transplant. 1993 May-Jun;12(3):508–512. [PubMed] [Google Scholar]\n\nBraf ZF, Altmann G, Ostfeld E. Fungal infections after renal transplantation. Isr J Med Sci. 1976 Jul;12(7):674–677. [PubMed] [Google Scholar]\n\nBranger B, Gouby A, Oulès R, Balducchi JP, Mourad G, Fourcade J, Mion C, Duntz F, Ramuz M. Mycobacterium haemophilum and mycobacterium xenopi associated infection in a renal transplant patient. Clin Nephrol. 1985 Jan;23(1):46–49. [PubMed] [Google Scholar]\n\nBrayman KL, Dafoe DC, Smythe WR, Barker CF, Perloff LJ, Naji A, Fox IJ, Grossman RA, Jorkasky DK, Starr SE, et al. Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine. Interim results of a randomized controlled trial. Arch Surg. 1988 Dec;123(12):1502–1508. [PubMed] [Google Scholar]\n\nBrayman KL, Stephanian E, Matas AJ, Schmidt W, Payne WD, Sutherland DE, Gores PF, Najarian JS, Dunn DL. Analysis of infectious complications occurring after solid-organ transplantation. Arch Surg. 1992 Jan;127(1):38–48. [PubMed] [Google Scholar]\n\nBreinig MK, Zitelli B, Starzl TE, Ho M. Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation. J Infect Dis. 1987 Aug;156(2):273–279. [PMC free article] [PubMed] [Google Scholar]\n\nBrems JJ, Hiatt JR, Klein AS, Hart J, el-Khoury G, Winston D, Millis JM, Busuttil RW. Disseminated aspergillosis complicating orthotopic liver transplantation for fulminant hepatic failure refractory to corticosteroid therapy. Transplantation. 1988 Sep;46(3):479–481. [PubMed] [Google Scholar]\n\nBren A, Kandus A, Lindic J, Varl J. Fluconazole in the treatment of fungal infections in kidney-transplanted patients. Transplant Proc. 1992 Dec;24(6):2765–2766. [PubMed] [Google Scholar]\n\nBrett MT, Kwan JT, Bending MR. Caecal perforation in a renal transplant patient with disseminated histoplasmosis. J Clin Pathol. 1988 Sep;41(9):992–995. [PMC free article] [PubMed] [Google Scholar]\n\nBritt RH, Enzmann DR, Remington JS. Intracranial infection in cardiac transplant recipients. Ann Neurol. 1981 Feb;9(2):107–119. [PubMed] [Google Scholar]\n\nBritt W, Fay J, Seals J, Kensil C. Formulation of an immunogenic human cytomegalovirus vaccine: responses in mice. J Infect Dis. 1995 Jan;171(1):18–25. [PubMed] [Google Scholar]\n\nBrooks RG, Hofflin JM, Jamieson SW, Stinson EB, Remington JS. Infectious complications in heart-lung transplant recipients. Am J Med. 1985 Oct;79(4):412–422. [PubMed] [Google Scholar]\n\nBubak ME, Porayko MK, Krom RA, Wiesner RH. Complications of liver biopsy in liver transplant patients: increased sepsis associated with choledochojejunostomy. Hepatology. 1991 Dec;14(6):1063–1065. [PubMed] [Google Scholar]\n\nBuffington GA, Dominguez JH, Piering WF, Hebert LA, Kauffman HM, Jr, Lemann J., Jr Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function. JAMA. 1976 Oct 25;236(17):1958–1960. [PubMed] [Google Scholar]\n\nBuhles WC, Jr, Mastre BJ, Tinker AJ, Strand V, Koretz SH. Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 3):S495–S506. [PubMed] [Google Scholar]\n\nBurdelski M, Schmidt K, Hoyer PF, Bernsau U, Galaske R, Brodehl J, Ringe B, Lauchart W, Wonigeit K, Pichlmayr R. Liver transplantation in children: the Hannover experience. Transplant Proc. 1987 Aug;19(4):3277–3281. [PubMed] [Google Scholar]\n\nBurke EM, Karp DL, Wu TC, Corio RL. Atypical oral presentation of herpes simplex virus infection in a patient after orthotopic liver transplantation. Eur Arch Otorhinolaryngol. 1994;251(5):301–303. [PubMed] [Google Scholar]\n\nBurkhart CG, Dvorak N, Stockard H. An unusual case of tinea versicolor in an immunosuppressed patient. Cutis. 1981;27(1):56–58. [PubMed] [Google Scholar]\n\nButka BJ, Bennett SR, Johnson AC. Disseminated inoculation blastomycosis in a renal transplant recipient. Am Rev Respir Dis. 1984 Dec;130(6):1180–1183. [PubMed] [Google Scholar]\n\nByl B, Jacobs F, Antoine M, Depierreux M, Serruys E, Primo G, Thys JP. Mediastinitis caused by Aspergillus fumigatus with ruptured aortic pseudoaneurysm in a heart transplant recipient: case study. Heart Lung. 1993 Mar-Apr;22(2):145–147. [PubMed] [Google Scholar]\n\nByrd BF, 3rd, Weiner MH, McGee ZA. Aspergillus spinal epidural abscess. JAMA. 1982 Dec 17;248(23):3138–3139. [PubMed] [Google Scholar]\n\nCaccamo L, Colledan M, Gridelli B, Rossi G, Doglia M, Gatti S, Ghidoni P, Lucianetti A, Lunghi G, Maggi U, et al. Hepatitis C virus infection in liver allograft recipients. Arch Virol Suppl. 1993;8:291–304. [PubMed] [Google Scholar]\n\nCagle PT, Buffone G, Holland VA, Samo T, Demmler GJ, Noon GP, Lawrence EC. Semiquantitative measurement of cytomegalovirus DNA in lung and heart-lung transplant patients by in vitro DNA amplification. Chest. 1992 Jan;101(1):93–96. [PubMed] [Google Scholar]\n\nCarbone KM, Pennington LR, Gimenez LF, Burrow CR, Watson AJ. Mucormycosis in renal transplant patients--a report of two cases and review of the literature. Q J Med. 1985 Dec;57(224):825–831. [PubMed] [Google Scholar]\n\nCarrier M, Pelletier GB, Cartier R, Leclerc Y, Pelletier LC. Prevention of herpes simplex virus infection by oral acyclovir after cardiac transplantation. Can J Surg. 1992 Oct;35(5):513–516. [PubMed] [Google Scholar]\n\nCarter JM, Green WR, Callender CO, Peters B. Pulmonary cavitation with Nocardia and Aspergillus in a renal transplant patient. J Natl Med Assoc. 1990 Jul;82(7):527–531. [PMC free article] [PubMed] [Google Scholar]\n\nCastaldo P, Stratta RJ, Wood RP, Markin RS, Patil KD, Shaefer MS, Langnas AN, Reed EC, Li SJ, Pillen TJ, et al. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg. 1991 Feb;126(2):149–156. [PubMed] [Google Scholar]\n\nCastaldo P, Stratta RJ, Wood RP, Markin RS, Patil KD, Shaefer MS, Langnas AN, Reed EC, Li S, Pillen TJ, et al. Fungal disease in liver transplant recipients: a multivariate analysis of risk factors. Transplant Proc. 1991 Feb;23(1 Pt 2):1517–1519. [PubMed] [Google Scholar]\n\nCastaldo P, Stratta RJ, Wood RP, Markin RS, Patil KD, Shaefer MS, Langnas AN, Shaw BW., Jr Fungal infections in liver allograft recipients. Transplant Proc. 1991 Jun;23(3):1967–1967. [PubMed] [Google Scholar]\n\nCastelli C, Benazzo F, Minoli L, Marone P, Seghezzi R, Carlizzi CN. Aspergillus infection of the L3-L4 disc space in an immunosuppressed heart transplant patient. Spine (Phila Pa 1976) 1990 Dec;15(12):1369–1373. [PubMed] [Google Scholar]\n\nCaya JG, Farmer SG, Williams GA, Franson TR, Komorowski RA, Kies JC. Bilateral Pseudallescheria boydii endophthalmitis in an immunocompromised patient. Wis Med J. 1988 Mar;87(3):11–14. [PubMed] [Google Scholar]\n\nCerrina J, Bavoux E, Le Roy Ladurie F, Herve P, Lafont D, Simonneau G, Dartevelle P. Ganciclovir treatment of cytomegalovirus infection in heart-lung and double-lung transplant recipients. Transplant Proc. 1991 Feb;23(1 Pt 2):1174–1175. [PubMed] [Google Scholar]\n\nChang H, Wu JD, Cheng KK, Tseng HH. Epstein-Barr virus-associated lymphoproliferative disorders in oral cavity after heart transplantation: report of a case. J Formos Med Assoc. 1994 Apr;93(4):332–336. [PubMed] [Google Scholar]\n\nChang RS, Lewis JP, Reynolds RD, Sullivan MJ, Neuman J. Oropharyngeal excretion of Epstein-Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts. Ann Intern Med. 1978 Jan;88(1):34–40. [PubMed] [Google Scholar]\n\nChaparro C, Maurer JR, Chamberlain D, De Hoyos A, Winton T, Westney G, Kesten S. Causes of death in lung transplant recipients. J Heart Lung Transplant. 1994 Sep-Oct;13(5):758–766. [PubMed] [Google Scholar]\n\nChapman LE, Folks TM, Salomon DR, Patterson AP, Eggerman TE, Noguchi PD. Xenotransplantation and xenogeneic infections. N Engl J Med. 1995 Nov 30;333(22):1498–1501. [PubMed] [Google Scholar]\n\nChatterjee SN, Chang RS. A prospective study of oropharyngeal excretion of Epstein-Barr virus in renal homograft recipients. Scand J Infect Dis. 1982;14(2):95–98. [PubMed] [Google Scholar]\n\nChave JP, David S, Wauters JP, Van Melle G, Francioli P. Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients. AIDS. 1991 Aug;5(8):927–932. [PubMed] [Google Scholar]\n\nCheeseman SH, Rubin RH, Stewart JA, Tolkoff-Rubin NE, Cosimi AB, Cantell K, Gilbert J, Winkle S, Herrin JT, Black PH, et al. Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med. 1979 Jun 14;300(24):1345–1349. [PubMed] [Google Scholar]\n\nChou SW. Cytomegalovirus infection and reinfection transmitted by heart transplantation. J Infect Dis. 1987 May;155(5):1054–1056. [PubMed] [Google Scholar]\n\nChugh KS, Sakhuja V, Jain S, Singh V, Tarafdar A, Joshi K, Gupta KL, Minz M. Fungal infections in renal allograft recipients. Transplant Proc. 1992 Oct;24(5):1940–1942. [PubMed] [Google Scholar]\n\nChugh KS, Sakhuja V, Jain S, Talwar P, Minz M, Joshi K, Indudhara R. High mortality in systemic fungal infections following renal transplantation in third-world countries. Nephrol Dial Transplant. 1993;8(2):168–172. [PubMed] [Google Scholar]\n\nCofer JB, Morris CA, Sutker WL, Husberg BS, Goldstein RM, Gonwa TA, Klintmalm GB. A randomized double-blind study of the effect of prophylactic immune globulin on the incidence and severity of CMV infection in the liver transplant recipient. Transplant Proc. 1991 Feb;23(1 Pt 2):1525–1527. [PubMed] [Google Scholar]\n\nCohen AT, O'Grady JG, Sutherland S, Sallie R, Tan KC, Williams R. Controlled trial of prophylactic versus therapeutic use of ganciclovir after liver transplantation in adults. J Med Virol. 1993 May;40(1):5–9. [PubMed] [Google Scholar]\n\nCohen IM, Galgiani JN, Potter D, Ogden DA. Coccidioidomycosis in renal replacement therapy. Arch Intern Med. 1982 Mar;142(3):489–494. [PubMed] [Google Scholar]\n\nCohen SG, Greenberg MS. Rhinomaxillary mucormycosis in a kidney transplant patient. Oral Surg Oral Med Oral Pathol. 1980 Jul;50(1):33–38. [PubMed] [Google Scholar]\n\nCollins LA, Samore MH, Roberts MS, Luzzati R, Jenkins RL, Lewis WD, Karchmer AW. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis. 1994 Sep;170(3):644–652. [PubMed] [Google Scholar]\n\nColombo JL, Sammut PH, Langnas AN, Shaw BW., Jr The spectrum of Pneumocystis carinii infection after liver transplantation in children. Transplantation. 1992 Oct;54(4):621–624. [PubMed] [Google Scholar]\n\nColonna JO, 2nd, Winston DJ, Brill JE, Goldstein LI, Hoff MP, Hiatt JR, Quinones-Baldrich W, Ramming KP, Busuttil RW. Infectious complications in liver transplantation. Arch Surg. 1988 Mar;123(3):360–364. [PubMed] [Google Scholar]\n\nConces DJ, Jr, Vix VA, Tarver RD. Pleural cryptococcosis. J Thorac Imaging. 1990 Apr;5(2):84–86. [PubMed] [Google Scholar]\n\nConti DJ, Freed BM, Gruber SA, Lempert N. Prophylaxis of primary cytomegalovirus disease in renal transplant recipients. A trial of ganciclovir vs immunoglobulin. Arch Surg. 1994 Apr;129(4):443–447. [PubMed] [Google Scholar]\n\nConti DJ, Tolkoff-Rubin NE, Baker GP, Jr, Doran M, Cosimi AB, Delmonico F, Auchincloss H, Jr, Russell PS, Rubin RH. Successful treatment of invasive fungal infection with fluconazole in organ transplant recipients. Transplantation. 1989 Oct;48(4):692–695. [PubMed] [Google Scholar]\n\nCooper DK, Novitzky D, Schlegel V, Muchmore JS, Cucchiara A, Zuhdi N. Successful management of symptomatic cytomegalovirus disease with ganciclovir after heart transplantation. J Heart Lung Transplant. 1991 Sep-Oct;10(5 Pt 1):656–663. [PubMed] [Google Scholar]\n\nCooper JF, Lichtenstein MJ, Graham BS, Schaffner W. Mycobacterium chelonae: a cause of nodular skin lesions with a proclivity for renal transplant recipients. Am J Med. 1989 Feb;86(2):173–177. [PubMed] [Google Scholar]\n\nCortet B, Richard R, Deprez X, Lucet L, Flipo RM, Le Loët X, Duquesnoy B, Delcambre B. Aspergillus spondylodiscitis: successful conservative treatment in 9 cases. J Rheumatol. 1994 Jul;21(7):1287–1291. [PubMed] [Google Scholar]\n\nCosta JM, Meyers AM, Botha JR, Conlan AA, Myburgh A. Mycobacterial infections in recipients of kidney allografts. A seventeen-year experience. Acta Med Port. 1988 Jan-Feb;1(1):51–57. [PubMed] [Google Scholar]\n\nCoutts II, Jegarajah S, Stark JE. Tuberculosis in renal transplant recipients. Br J Dis Chest. 1979 Apr;73(2):141–148. [PubMed] [Google Scholar]\n\nCox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, Lennette ET, Martinez OM, Krams SM, Berquist WE, So SK, Esquivel CO. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation. 1995 Feb 27;59(4):524–529. [PubMed] [Google Scholar]\n\nCrompton CH, Cheung RK, Donjon C, Miyazaki I, Feinmesser R, Hébert D, Dosch HM. Epstein-Barr virus surveillance after renal transplantation. Transplantation. 1994 Apr 27;57(8):1182–1189. [PubMed] [Google Scholar]\n\nCruz N, Ramírez-Muxó O, Bermúdez RH, Santiago-Delpín EA. Pulmonary infection with M. kansasii in a renal transplant patient. Nephron. 1980;26(4):187–188. [PubMed] [Google Scholar]\n\nCuende E, Barbadillo C, E-Mazzucchelli R, Isasi C, Trujillo A, Andréu JL. Candida arthritis in adult patients who are not intravenous drug addicts: report of three cases and review of the literature. Semin Arthritis Rheum. 1993 Feb;22(4):224–241. [PubMed] [Google Scholar]\n\nCuervas-Mons V, Julio Martinez A, Dekker A, Starzl TE, Van Thiel DH. Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases. Hepatology. 1986 May-Jun;6(3):495–501. [PMC free article] [PubMed] [Google Scholar]\n\nCuervas-Mons V, Millan I, Gavaler JS, Starzl TE, Van Thiel DH. Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology. 1986 Sep-Oct;6(5):922–927. [PMC free article] [PubMed] [Google Scholar]\n\nDa Cunha S, Ferreira E, Ramos I, Martins R, De Freitas L, Borges JL, Côrte-Real R, Mota A, Meliço-Silvestre A, Furtado AL. Cerebral toxoplasmosis after renal transplantation. Case report and review. Acta Med Port. 1994 Dec;7 (Suppl 1):S61–S66. [PubMed] [Google Scholar]\n\nD'Alessandro AM, Pirsch JD, Stratta RJ, Sollinger HW, Kalayoglu M, Belzer FO. Successful treatment of severe cytomegalovirus infections with ganciclovir and CMV hyperimmune globulin in liver transplant recipients. Transplant Proc. 1989 Jun;21(3):3560–3561. [PubMed] [Google Scholar]\n\nDaman LA, Hashimoto K, Kaplan RJ, Trent WG. Disseminated histoplasmosis in an immunosuppressed patient. South Med J. 1977 Mar;70(3):355–356. [PubMed] [Google Scholar]\n\nDaoud S, Garnier JL, Chossegros P, Chevallier P, Dubernard JM, Touraine JL. Hepatitis C virus infection in renal transplantation. Transplant Proc. 1995 Apr;27(2):1735–1735. [PubMed] [Google Scholar]\n\nDavies SF, Sarosi GA, Peterson PK, Khan M, Howard RJ, Simmons RL, Najarian JS. Disseminated histoplasmosis in renal transplant recipients. Am J Surg. 1979 May;137(5):686–691. [PubMed] [Google Scholar]\n\nDavis BR, Brumbach J, Sanders WJ, Wolinsky E. Skin lesions caused by Mycobacterium haemophilum. Ann Intern Med. 1982 Nov;97(5):723–724. [PubMed] [Google Scholar]\n\nDavis CL, Gretch DR, Carithers RL., Jr Hepatitis B and transplantation. Infect Dis Clin North Am. 1995 Dec;9(4):925–941. [PubMed] [Google Scholar]\n\nDavis CL, Springmeyer S, Gmerek BJ. Central nervous system side effects of ganciclovir. N Engl J Med. 1990 Mar 29;322(13):933–934. [PubMed] [Google Scholar]\n\nDavis CL, Harrison KL, McVicar JP, Forg PJ, Bronner MP, Marsh CL. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder. Clin Transplant. 1995 Feb;9(1):53–59. [PubMed] [Google Scholar]\n\nDe Biase L, Venditti M, Gallo P, Macchiarelli A, Tonelli E, Scibilia G, Marino B. Herpes simplex pneumonia in a heart transplant recipient. Recenti Prog Med. 1992 Jun;83(6):341–343. [PubMed] [Google Scholar]\n\nde Hemptinne B, Lamy ME, Salizzoni M, Cornu C, Mostin J, Fevery J, De Groote V, Otte JB. Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine). Transplant Proc. 1988 Feb;20(1 Suppl 1):652–655. [PubMed] [Google Scholar]\n\nde Koning J, van Dorp WT, van Es LA, van 't Wout JW, van der Woude FJ. Ganciclovir effectively treats cytomegalovirus disease after solid-organ transplantation, even during rejection treatment. Nephrol Dial Transplant. 1992;7(4):350–356. [PubMed] [Google Scholar]\n\nde la Mata M, Rufián S, Gómez F, Varo E, López-Cillero P, Costán G, Solórzano G, González R, Miño G, Pera C. Recurrent fulminant liver failure caused by hepatitis B virus after liver transplantation. J Clin Gastroenterol. 1994 Oct;19(3):238–241. [PubMed] [Google Scholar]\n\nDelaney V, Sumrani N, Hong JH, Sommer B. Mycobacterial infections in renal allograft recipients. Transplant Proc. 1993 Jun;25(3):2288–2289. [PubMed] [Google Scholar]\n\nDelgado R, Lumbreras C, Alba C, Pedraza MA, Otero JR, Gómez R, Moreno E, Noriega AR, Payá CV. Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. J Clin Microbiol. 1992 Jul;30(7):1876–1878. [PMC free article] [PubMed] [Google Scholar]\n\nDemetris AJ. Hepatitis B after liver transplantation: new names for unusual presentations. Gastroenterology. 1992 Oct;103(4):1355–1356. [PubMed] [Google Scholar]\n\nDennis C, Caine N, Sharples L, Smyth R, Higenbottam T, Stewart S, Wreghitt T, Large S, Wells FC, Wallwork J. Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant. 1993 Nov-Dec;12(6 Pt 1):893–902. [PubMed] [Google Scholar]\n\nDeusch E, End A, Grimm M, Graninger W, Klepetko W, Wolner E. Early bacterial infections in lung transplant recipients. Chest. 1993 Nov;104(5):1412–1416. [PubMed] [Google Scholar]\n\nDeVault GA, Jr, Brown ST, 3rd, Montoya SF, Jr, King JW, Rohr MS, McDonald JC. Disseminated strongyloidiasis complicating acute renal allograft rejection. Prolonged thiabendazole administration and successful retransplantation. Transplantation. 1982 Oct;34(4):220–221. [PubMed] [Google Scholar]\n\nDeVault GA, Jr, King JW, Rohr MS, Landreneau MD, Brown ST, 3rd, McDonald JC. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis. 1990 Jul-Aug;12(4):653–671. [PubMed] [Google Scholar]\n\nDe Vuyst D, Surmont I, Verhaegen J, Vanhaecke J. Tibial osteomyelitis due to Aspergillus flavus in a heart transplant patient. Infection. 1992 Jan-Feb;20(1):48–49. [PubMed] [Google Scholar]\n\nDhar JM, al-Khader AA, al-Sulaiman M, al-Hasani MK. Non-typhoid Salmonella in renal transplant recipients: a report of twenty cases and review of the literature. Q J Med. 1991 Mar;78(287):235–250. [PubMed] [Google Scholar]\n\nDodd LG, Nelson SD. Disseminated coccidioidomycosis detected by percutaneous liver biopsy in a liver transplant recipient. Am J Clin Pathol. 1990 Jan;93(1):141–144. [PubMed] [Google Scholar]\n\nDooley DP, Beckius ML, Jeffery BS, McAllister CK, Radentz WH, Feldman AR, Rinaldi MG, Bailey SR, Keeling JH. Phaeohyphomycotic cutaneous disease caused by Pleurophoma in a cardiac transplant patient. J Infect Dis. 1989 Mar;159(3):503–507. [PubMed] [Google Scholar]\n\nDowling JN, Pasculle AW, Frola FN, Zaphyr MK, Yee RB. Infections caused by Legionella micdadei and Legionella pneumophila among renal transplant recipients. J Infect Dis. 1984 May;149(5):703–713. [PubMed] [Google Scholar]\n\nDowling RD, Baladi N, Zenati M, Dummer JS, Kormos RL, Armitage JM, Yousem SA, Hardesty RL, Griffith BP. Disruption of the aortic anastomosis after heart-lung transplantation. Ann Thorac Surg. 1990 Jan;49(1):118–122. [PubMed] [Google Scholar]\n\nDreikorn K, Doerr HW, Geursen RG. Cytomegalovirus (CMV) infections in renal transplant recipients. Preliminary results of prophylaxis by an intramuscular human hyperimmune CMV IgG. Scand J Urol Nephrol Suppl. 1985;92:15–21. [PubMed] [Google Scholar]\n\nDummer JS. Pneumocystis carinii infections in transplant recipients. Semin Respir Infect. 1990 Mar;5(1):50–57. [PubMed] [Google Scholar]\n\nDummer JS, Armstrong J, Somers J, Kusne S, Carpenter BJ, Rosenthal JT, Ho M. Transmission of infection with herpes simplex virus by renal transplantation. J Infect Dis. 1987 Feb;155(2):202–206. [PubMed] [Google Scholar]\n\nDummer JS, Erb S, Breinig MK, Ho M, Rinaldo CR, Jr, Gupta P, Ragni MV, Tzakis A, Makowka L, Van Thiel D, et al. Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation. 1989 Jan;47(1):134–140. [PMC free article] [PubMed] [Google Scholar]\n\nDummer JS, Hardy A, Poorsattar A, Ho M. Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation. 1983 Sep;36(3):259–267. [PubMed] [Google Scholar]\n\nDummer JS, Montero CG, Griffith BP, Hardesty RL, Paradis IL, Ho M. Infections in heart-lung transplant recipients. Transplantation. 1986 Jun;41(6):725–729. [PubMed] [Google Scholar]\n\nDummer S, Kusne S. Liver transplantation and related infections. Semin Respir Infect. 1993 Sep;8(3):191–198. [PubMed] [Google Scholar]\n\nDuncan SR, Grgurich WF, Iacono AT, Burckart GJ, Yousem SA, Paradis IL, Williams PA, Johnson BA, Griffith BP. A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med. 1994 Jul;150(1):146–152. [PubMed] [Google Scholar]\n\nDuncan SR, Paradis IL, Dauber JH, Yousem SA, Hardesty RL, Griffith BP. Ganciclovir prophylaxis for cytomegalovirus infections in pulmonary allograft recipients. Am Rev Respir Dis. 1992 Nov;146(5 Pt 1):1213–1215. [PubMed] [Google Scholar]\n\nDunn DL, Gillingham KJ, Kramer MA, Schmidt WJ, Erice A, Balfour HH, Jr, Gores PF, Gruessner RW, Matas AJ, Payne WD, et al. A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation. Transplantation. 1994 Mar 27;57(6):876–884. [PubMed] [Google Scholar]\n\nDunn DL, Mayoral JL, Gillingham KJ, Loeffler CM, Brayman KL, Kramer MA, Erice A, Balfour HH, Jr, Fletcher CV, Bolman RM, 3rd, et al. Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation. 1991 Jan;51(1):98–106. [PubMed] [Google Scholar]\n\nDurand F, Bernuau J, Dupont B, Sauvanet A, Belghiti J, Degott C, Benhamou JP. Aspergillus intraabdominal abscess after liver transplantation successfully treated with itraconazole. Transplantation. 1992 Oct;54(4):734–735. [PubMed] [Google Scholar]\n\nDussaix E, Wood C. Cytomegalovirus infection in pediatric liver recipients. A virological survey and prophylaxis with CMV immune globulin and early DHPG treatment. Transplantation. 1989 Aug;48(2):272–274. [PubMed] [Google Scholar]\n\nDuston M, McHenry MC, Braun WF, Fieker DH, Gavan TL, Novick AC. Cryptococcal meningitis causing fever of unknown origin in renal transplant recipients: report of two cases initially diagnosed by urine cultures. Transplantation. 1981 Oct;32(4):334–336. [PubMed] [Google Scholar]\n\nDyall-Smith D, Trowell H, Mark A, Dyall-Smith M. Cutaneous squamous cell carcinomas and papillomaviruses in renal transplant recipients: a clinical and molecular biological study. J Dermatol Sci. 1991 May;2(3):139–146. [PubMed] [Google Scholar]\n\nEinsele H, Ehninger G, Steidle M, Vallbracht A, Müller M, Schmidt H, Saal JG, Waller HD, Müller CA. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet. 1991 Nov 9;338(8776):1170–1172. [PubMed] [Google Scholar]\n\nEisen HJ, Hicks D, Kant JA, Montone KT, Mull R, Pigott J, Tomaszewski JE. Diagnosis of posttransplantation lymphoproliferative disorder by endomyocardial biopsy in a cardiac allograft recipient. J Heart Lung Transplant. 1994 Mar-Apr;13(2):241–245. [PubMed] [Google Scholar]\n\nEisenmann D, Knipp H, Laube H, Stegmann T. Prevention of cytomegalovirus disease in heart transplant recipients by prophylaxis with cytomegalovirus hyperimmune globulin plus oral acyclovir. Transplant Proc. 1990 Oct;22(5):2322–2323. [PubMed] [Google Scholar]\n\nElinder CG, Andersson J, Bolinder G, Tydén G. Effectiveness of low-dose cotrimoxazole prophylaxis against Pneumocystis carinii pneumonia after renal and/or pancreas transplantation. Transpl Int. 1992 May;5(2):81–84. [PubMed] [Google Scholar]\n\nElkhammas EA, Henry ML, Tesi RJ, Mutabagani K, Bryan BA, Ferguson RM. Cytomegalovirus prevention in combined kidney-pancreas transplantation using acyclovir alone. Transplant Proc. 1994 Apr;26(2):436–436. [PubMed] [Google Scholar]\n\nElkins CC, Frist WH, Dummer JS, Stewart JR, Merrill WH, Carden KA, Bender HW., Jr Cytomegalovirus disease after heart transplantation: is acyclovir prophylaxis indicated? Ann Thorac Surg. 1993 Dec;56(6):1267–1273. [PubMed] [Google Scholar]\n\nEnd A, Helbich T, Wisser W, Dekan G, Klepetko W. The pulmonary nodule after lung transplantation. Cause and outcome. Chest. 1995 May;107(5):1317–1322. [PubMed] [Google Scholar]\n\nErice A, Holm MA, Gill PC, Henry S, Dirksen CL, Dunn DL, Hillam RP, Balfour HH., Jr Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. J Clin Microbiol. 1992 Nov;30(11):2822–2825. [PMC free article] [PubMed] [Google Scholar]\n\nErice A, Jordan MC, Chace BA, Fletcher C, Chinnock BJ, Balfour HH., Jr Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts. JAMA. 1987 Jun 12;257(22):3082–3087. [PubMed] [Google Scholar]\n\nErice A, Rhame FS, Heussner RC, Dunn DL, Balfour HH., Jr Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. Rev Infect Dis. 1991 Jul-Aug;13(4):537–547. [PubMed] [Google Scholar]\n\nErlich KS, Mills J, Chatis P, Mertz GJ, Busch DF, Follansbee SE, Grant RM, Crumpacker CS. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1989 Feb 2;320(5):293–296. [PubMed] [Google Scholar]\n\nEsquivel CO, Jaffe R, Gordon RD, Iwatsuki S, Shaw BW, Jr, Starzl TE. Liver rejection and its differentiation from other causes of graft dysfunction. Semin Liver Dis. 1985 Nov;5(4):369–374. [PubMed] [Google Scholar]\n\nFaggian G, Livi U, Bortolotti U, Mazzucco A, Stellin G, Chiominto B, Vivani MA, Gallucci V. Itraconazole therapy for acute invasive pulmonary aspergillosis in heart transplantation. Transplant Proc. 1989 Feb;21(1 Pt 3):2506–2507. [PubMed] [Google Scholar]\n\nFairley JW, Hunt BJ, Glover GW, Radley-Smith RC, Yacoub MH. Unusual lymphoproliferative oropharyngeal lesions in heart and heart-lung transplant recipients. J Laryngol Otol. 1990 Sep;104(9):720–724. [PubMed] [Google Scholar]\n\nFarr B, Beacham BE, Atuk NO. Cutaneous histoplasmosis after renal transplantation. South Med J. 1981 May;74(5):635–637. [PubMed] [Google Scholar]\n\nFaulds D, Heel RC. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs. 1990 Apr;39(4):597–638. [PubMed] [Google Scholar]\n\nFehir KM, Decker WA, Samo T, Young JB, Lederer E, Lawrence EC. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation. Transplant Proc. 1989 Feb;21(1 Pt 3):3107–3109. [PubMed] [Google Scholar]\n\nFéray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Urdea M, Reynes M, Bréchot C, Bismuth H. The course of hepatitis C virus infection after liver transplantation. Hepatology. 1994 Nov;20(5):1137–1143. [PubMed] [Google Scholar]\n\nFerraz AS, Figueiredo JF. Transmission of Chagas' disease through transplanted kidney: occurrence of the acute form of the disease in two recipients from the same donor. Rev Inst Med Trop Sao Paulo. 1993 Sep-Oct;35(5):461–463. [PubMed] [Google Scholar]\n\nFerreiro JA, Robert MA, Townsend J, Vinters HV. Neuropathologic findings after liver transplantation. Acta Neuropathol. 1992;84(1):1–14. [PubMed] [Google Scholar]\n\nFinkelstein R, Singer P, Lefler E. Catheter-related fungemia caused by trichosporon beigelii in non-neutropenic patients. Am J Med. 1989 Jan;86(1):133–133. [PubMed] [Google Scholar]\n\nFinn WF. CMV-enriched immune globulin produces consistent reliable results in renal transplant patients. Transplantation. 1993 Aug;56(2):491–491. [PubMed] [Google Scholar]\n\nFisher J, Tuazon CU, Geelhoed GW. Mucormycosis in transplant patients. Am Surg. 1980 May;46(5):315–322. [PubMed] [Google Scholar]\n\nFishman JA. Pneumocystis carinii and parasitic infections in transplantation. Infect Dis Clin North Am. 1995 Dec;9(4):1005–1044. [PubMed] [Google Scholar]\n\nFlume PA, Egan TM, Paradowski LJ, Detterbeck FC, Thompson JT, Yankaskas JR. Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med. 1994 Jun;149(6):1601–1607. [PubMed] [Google Scholar]\n\nFojtasek MF, Kelly MT. Isolation of Mycobacterium chelonei with the lysis-centrifugation blood culture technique. J Clin Microbiol. 1982 Aug;16(2):403–405. [PMC free article] [PubMed] [Google Scholar]\n\nForbes GM, Harvey FA, Philpott-Howard JN, O'Grady JG, Jensen RD, Sahathevan M, Casewell MW, Williams R. Nocardiosis in liver transplantation: variation in presentation, diagnosis and therapy. J Infect. 1990 Jan;20(1):11–19. [PubMed] [Google Scholar]\n\nFowler CG, Lindsay I, Levin J, Sweny P, Fernando ON, Moorhead JF. Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft recipient. Br Med J (Clin Res Ed) 1982 Nov 13;285(6352):1394–1394. [PMC free article] [PubMed] [Google Scholar]\n\nFox AS, Tolpin MD, Baker AL, Broelsch CE, Whittington PF, Jackson T, Thistlethwaite JR, Stuart FP. Seropositivity in liver transplant recipients as a predictor of cytomegalovirus disease. J Infect Dis. 1988 Feb;157(2):383–385. [PubMed] [Google Scholar]\n\nFox BC, Sollinger HW, Belzer FO, Maki DG. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med. 1990 Sep;89(3):255–274. [PubMed] [Google Scholar]\n\nFraser DW, Buxton AE, Naji A, Barker CF, Rudnick M, Weinstein AJ. Disseminated mycobacterium kansasii infection presenting as cellulitis in a recipient of a renal homograft. Am Rev Respir Dis. 1975 Jul;112(1):125–129. [PubMed] [Google Scholar]\n\nFreise CE, Pons V, Lake J, Burke E, Ascher NL, Roberts JP. Comparison of three regimens for cytomegalovirus prophylaxis in 147 liver transplant recipients. Transplant Proc. 1991 Feb;23(1 Pt 2):1498–1500. [PubMed] [Google Scholar]\n\nFrey DJ, Matas AJ, Gillingham KJ, Canafax D, Payne WD, Dunn DL, Sutherland DE, Najarian JS. Sequential therapy--a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients. Transplantation. 1992 Jul;54(1):50–56. [PubMed] [Google Scholar]\n\nFrick T, Fryd DS, Goodale RL, Simmons RL, Sutherland DE, Najarian JS. Incidence and treatment of candida esophagitis in patients undergoing renal transplantation. Data from the Minnesota prospective randomized trial of cyclosporine versus antilymphocyte globulin-azathioprine. Am J Surg. 1988 Feb;155(2):311–313. [PubMed] [Google Scholar]\n\nGallis HA, Berman RA, Cate TR, Hamilton JD, Gunnells JC, Stickel DL. Fungal infection following renal transplantation. Arch Intern Med. 1975 Sep;135(9):1163–1172. [PubMed] [Google Scholar]\n\nGane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996 Mar 28;334(13):815–820. [PubMed] [Google Scholar]\n\nGarnier JL, Berger F, Betuel H, Vuillaume M, Chapuis-Cellier C, Blanc N, Faure JL, Dubernard JM, Lenoir G, Touraine JL. Epstein-Barr virus associated lymphoproliferative diseases (B cell lymphoma) after transplantation. Nephrol Dial Transplant. 1989;4(9):818–823. [PubMed] [Google Scholar]\n\nGelpi J, Chernoff A, Snydman D, Freeman RB, Rohrer RJ, Haug CE. Aspergillus brain abscess after liver transplantation with long-term survival. A case report. Transplantation. 1994 Jun 15;57(11):1669–1672. [PubMed] [Google Scholar]\n\nGeorge DL, Arnow PM, Fox A, Thistlethwaite JR, Emond JC, Broelsch CE, Whitington PF. Patterns of infection after pediatric liver transplantation. Am J Dis Child. 1992 Aug;146(8):924–929. [PubMed] [Google Scholar]\n\nGeorge DL, Arnow PM, Fox AS, Baker AL, Thistlethwaite JR, Emond JC, Whitington PF, Broelsch CE. Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis. 1991 May-Jun;13(3):387–396. [PubMed] [Google Scholar]\n\nGershon AA. Immunizations for pediatric transplant patients. Kidney Int Suppl. 1993 Oct;43:S87–S90. [PubMed] [Google Scholar]\n\nGlazer JP, Friedman HM, Grossman RA, Starr SE, Barker CF, Perloff LJ, Huang ES, Plotkin SA. Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial. Ann Intern Med. 1979 Nov;91(5):676–683. [PubMed] [Google Scholar]\n\nGlowacki LS, Smaill FM. Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis. Clin Transplant. 1994 Feb;8(1):10–18. [PubMed] [Google Scholar]\n\nGoffin E, Pirson Y, Cornu C, Geubel A, Squifflet JP, van Ypersele de Strihou C. Outcome of HCV infection after renal transplantation. Kidney Int. 1994 Feb;45(2):551–555. [PubMed] [Google Scholar]\n\nGombert ME, Goldstein EJ, Corrado ML, Stein AJ, Butt KM. Disseminated Mycobacterium marinum infection after renal transplantation. Ann Intern Med. 1981 Apr;94(4 Pt 1):486–487. [PubMed] [Google Scholar]\n\nGoodman JL. Possible transmission of herpes simplex virus by organ transplantation. Transplantation. 1989 Apr;47(4):609–613. [PubMed] [Google Scholar]\n\nGootenberg JE, Stewart CL, Vetro SW, Bellanti JA. Lack of graft rejection in a renal transplant recipient with AIDS. Ann Allergy. 1991 Aug;67(2 Pt 1):123–125. [PubMed] [Google Scholar]\n\nGordon SM, Gal AA, Hertzler GL, Bryan JA, Perlino C, Kanter KR. Diagnosis of pulmonary toxoplasmosis by bronchoalveolar lavage in cardiac transplant recipients. Diagn Cytopathol. 1993 Dec;9(6):650–654. [PubMed] [Google Scholar]\n\nGorensek MJ, Carey WD, Vogt D, Goormastic M. A multivariate analysis of risk factors for cytomegalovirus infection in liver-transplant recipients. Gastroenterology. 1990 May;98(5 Pt 1):1326–1332. [PubMed] [Google Scholar]\n\nGorensek MJ, Carey WD, Washington JA, 2nd, Vogt DP, Broughan TA, Westveer MK. Selective bowel decontamination with quinolones and nystatin reduces gram-negative and fungal infections in orthotopic liver transplant recipients. Cleve Clin J Med. 1993 Mar-Apr;60(2):139–144. [PubMed] [Google Scholar]\n\nGouby A, Branger B, Oules R, Ramuz M. Two cases of Mycobacterium haemophilum infection in a renal-dialysis unit. J Med Microbiol. 1988 Apr;25(4):299–300. [PubMed] [Google Scholar]\n\nGould FK, Freeman R, Taylor CE, Ashcroft T, Dark JH, Corris PA. Prophylaxis and management of cytomegalovirus pneumonitis after lung transplantation: a review of experience in one center. J Heart Lung Transplant. 1993 Jul-Aug;12(4):695–699. [PubMed] [Google Scholar]\n\nGraham DA, Kinyoun JL, George DP. Endogenous Aspergillus endophthalmitis after lung transplantation. Am J Ophthalmol. 1995 Jan;119(1):107–109. [PubMed] [Google Scholar]\n\nGranier F, Kanitakis J, Hermier C, Zhu YY, Thivolet J. Localized cutaneous cryptococcosis successfully treated with ketoconazole. J Am Acad Dermatol. 1987 Jan;16(1 Pt 2):243–249. [PubMed] [Google Scholar]\n\nGrant SM, Clissold SP. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs. 1989 Mar;37(3):310–344. [PubMed] [Google Scholar]\n\nGrattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 1989 Jun 23;261(24):3561–3566. [PubMed] [Google Scholar]\n\nGrauhan O, Lohmann R, Lemmens P, Schattenfroh N, Jonas S, Keck H, Raakow R, Langrehr J, Bechstein W, Blumhardt G, et al. Mycobacterial infection after liver transplantation. Langenbecks Arch Chir. 1995;380(3):171–175. [PubMed] [Google Scholar]\n\nGrauhan O, Lohmann R, Lemmens P, Schattenfroh N, Keck H, Klein E, Raakow R, Jonas S, Langrehr JM, Bechstein W, et al. Fungal infections in liver transplant recipients. Langenbecks Arch Chir. 1994;379(6):372–375. [PubMed] [Google Scholar]\n\nGray J, Wreghitt TG, Pavel P, Smyth RL, Parameshwar J, Stewart S, Cary N, Large S, Wallwork J. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact. J Heart Lung Transplant. 1995 Jul-Aug;14(4):640–646. [PubMed] [Google Scholar]\n\nGraybill JR, Silva J, Jr, Fraser DW, Lordon R, Rogers E. Disseminated mycobacteriosis due to Mycobacterium abcessus in two recipients of renal homografts. Am Rev Respir Dis. 1974 Jan;109(1):4–10. [PubMed] [Google Scholar]\n\nGreen M, Reyes J, Nour B, Beatty D, Kaufman M, Wilson J, Todo S, Tzakis A. Randomized trial of ganciclovir followed by high-dose oral acyclovir vs ganciclovir alone in the prevention of cytomegalovirus disease in pediatric liver transplant recipients: preliminary analysis. Transplant Proc. 1994 Feb;26(1):173–174. [PubMed] [Google Scholar]\n\nGreen M, Shlaes JH, Barbadora K, Shlaes DM. Bacteremia due to vancomycin-dependent Enterococcus faecium. Clin Infect Dis. 1995 Mar;20(3):712–714. [PubMed] [Google Scholar]\n\nGreen M, Wald ER, Fricker FJ, Griffith BP, Trento A. Infections in pediatric orthotopic heart transplant recipients. Pediatr Infect Dis J. 1989 Feb;8(2):87–93. [PubMed] [Google Scholar]\n\nGreen M, Wald ER, Tzakis A, Todo S, Starzl TE. Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review. Rev Infect Dis. 1991 Jul-Aug;13(4):653–657. [PMC free article] [PubMed] [Google Scholar]\n\nGreene NB, Baughman RP, Kim CK, Roselle GA. Failure of ketoconazole in an immunosuppressed patient with pulmonary blastomycosis. Chest. 1985 Oct;88(4):640–641. [PubMed] [Google Scholar]\n\nGrekas D, Alivanis P, Kiriazopoulou V, Dioudis C, Sioulis A, Derveniotis V, Tourkantonis A. Influenza vaccination on renal transplant patients is safe and serologically effective. Int J Clin Pharmacol Ther Toxicol. 1993 Nov;31(11):553–556. [PubMed] [Google Scholar]\n\nGribetz AR, Chuang MT, Burrows L, Teirstein AS. Rhizopus lung abscess in renal transplant patient successfully treated by lobectomy. Chest. 1980 Jan;77(1):102–104. [PubMed] [Google Scholar]\n\nGriffith BP, Bando K, Hardesty RL, Armitage JM, Keenan RJ, Pham SM, Paradis IL, Yousem SA, Komatsu K, Konishi H, et al. A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. Transplantation. 1994 Mar 27;57(6):848–851. [PMC free article] [PubMed] [Google Scholar]\n\nGrose C, Henle W, Horwitz MS. Primary Epstein-Barr virus infection in a renal transplant recipient. South Med J. 1977 Nov;70(11):1276–1278. [PubMed] [Google Scholar]\n\nGrossi P, De Maria R, Caroli A, Zaina MS, Minoli L. Infections in heart transplant recipients: the experience of the Italian heart transplantation program. Italian Study Group on Infections in Heart Transplantation. J Heart Lung Transplant. 1992 Sep-Oct;11(5):847–866. [PubMed] [Google Scholar]\n\nGrossi P, Ippoliti GB, Goggi C, Cremaschi P, Scaglia M, Minoli L. Pneumocystis carinii pneumonia in heart transplant recipients. Infection. 1993 Mar-Apr;21(2):75–79. [PubMed] [Google Scholar]\n\nGrossi P, Revello MG, Minoli L, Percivalle E, Zavattoni M, Poma G, Martinelli L, Gerna G. Three-year experience with human cytomegalovirus infections in heart transplant recipients. J Heart Transplant. 1990 Nov-Dec;9(6):712–719. [PubMed] [Google Scholar]\n\nGrundmann R, Wienand P, Runde A, Baldamus CA, Arns W, Burkhardt U. CMV-Hyperimmunoglobulinprophylaxe nach Nierentransplantation. Ergebnisse einer prospektiv randomisierten Studie. Dtsch Med Wochenschr. 1987 May 22;112(21):827–831. [PubMed] [Google Scholar]\n\nGryzan S, Paradis IL, Zeevi A, Duquesnoy RJ, Dummer JS, Griffith BP, Hardesty RL, Trento A, Nalesnik MA, Dauber JH. Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Implications for lung defense and allograft survival. Am Rev Respir Dis. 1988 Jun;137(6):1268–1274. [PubMed] [Google Scholar]\n\nGudnason T, Belani KK, Balfour HH., Jr Ganciclovir treatment of cytomegalovirus disease in immunocompromised children. Pediatr Infect Dis J. 1989 Jul;8(7):436–440. [PubMed] [Google Scholar]\n\nGuerin C, Pozzetto B, Broyet C, Gaudin O, Berthoux F. Ganciclovir therapy of symptomatic cytomegalovirus infection in renal transplant recipients. Nephrol Dial Transplant. 1989;4(10):906–910. [PubMed] [Google Scholar]\n\nGuettier C, Hamilton-Dutoit S, Guillemain R, Farge D, Amrein C, Vulser C, Hofman P, Carpentier A, Diebold J. Primary gastrointestinal malignant lymphomas associated with Epstein-Barr virus after heart transplantation. Histopathology. 1992 Jan;20(1):21–28. [PubMed] [Google Scholar]\n\nGuillemain R, Lavarde V, Amrein C, Chevalier P, Guinvarc'h A, Glotz D. Invasive aspergillosis after transplantation. Transplant Proc. 1995 Feb;27(1):1307–1309. [PubMed] [Google Scholar]\n\nGullberg RM, Quintanilla A, Levin ML, Williams J, Phair JP. Sporotrichosis: recurrent cutaneous, articular, and central nervous system infection in a renal transplant recipient. Rev Infect Dis. 1987 Mar-Apr;9(2):369–375. [PubMed] [Google Scholar]\n\nGustafson TL, Schaffner W, Lavely GB, Stratton CW, Johnson HK, Hutcheson RH., Jr Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis. 1983 Aug;148(2):230–238. [PubMed] [Google Scholar]\n\nHaagsma EB, Klompmaker IJ, Grond J, Bijleveld CM, The TH, Schirm J, Gips CH, Slooff MJ. Herpes virus infections after orthotopic liver transplantation. Transplant Proc. 1987 Oct;19(5):4054–4056. [PubMed] [Google Scholar]\n\nHachisuka H, Matsumoto T, Kusuhara M, Nomura H, Nakano S, Sasai Y. Cutaneous phaeohyphomycosis caused by Exophiala jeanselmei after renal transplantation. Int J Dermatol. 1990 Apr;29(3):198–200. [PubMed] [Google Scholar]\n\nHadley S, Samore MH, Lewis WD, Jenkins RL, Karchmer AW, Hammer SM. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation. 1995 Mar 27;59(6):851–859. [PubMed] [Google Scholar]\n\nHaim S, Better OS, Lichtig C, Erlik D, Barzilai A. Rhinocerebral mucormycosis following kidney transplantation. Isr J Med Sci. 1970 Sep-Oct;6(5):646–649. [PubMed] [Google Scholar]\n\nHall JC, Brewer JH, Crouch TT, Watson KR. Cryptococcal cellulitis with multiple sites of involvement. J Am Acad Dermatol. 1987 Aug;17(2 Pt 2):329–332. [PubMed] [Google Scholar]\n\nHall JC, Brewer JH, Reed WA, Steinhaus DM, Watson KR. Cutaneous mucormycosis in a heart transplant patient. Cutis. 1988 Sep;42(3):183–186. [PubMed] [Google Scholar]\n\nHall KA, Copeland JG, Zukoski CF, Sethi GK, Galgiani JN. Markers of coccidioidomycosis before cardiac or renal transplantation and the risk of recurrent infection. Transplantation. 1993 Jun;55(6):1422–1424. [PubMed] [Google Scholar]\n\nHall KA, Sethi GK, Rosado LJ, Martinez JD, Huston CL, Copeland JG. Coccidioidomycosis and heart transplantation. J Heart Lung Transplant. 1993 May-Jun;12(3):525–526. [PubMed] [Google Scholar]\n\nHall WA, Martinez AJ, Dummer JS, Griffith BP, Hardesty RL, Bahnson HT, Lunsford LD. Central nervous system infections in heart and heart-lung transplant recipients. Arch Neurol. 1989 Feb;46(2):173–177. [PubMed] [Google Scholar]\n\nHall WA, Martinez AJ, Dummer JS, Lunsford LD. Nocardial brain abscess: diagnostic and therapeutic use of stereotactic aspiration. Surg Neurol. 1987 Aug;28(2):114–118. [PubMed] [Google Scholar]\n\nHamdy NA, Andrew SM, Shortland JR, Boletis J, Raftery AT, Kanis JA, Brown CB. Fatal cardiac zygomycosis in a renal transplant patient treated with desferrioxamine. Nephrol Dial Transplant. 1989;4(10):911–913. [PubMed] [Google Scholar]\n\nHammer GS, Bottone EJ, Hirschman SZ. Mucormycosis in a transplant recipient. Am J Clin Pathol. 1975 Sep;64(3):389–398. [PubMed] [Google Scholar]\n\nHanto DW. Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med. 1995;46:381–394. [PubMed] [Google Scholar]\n\nHanto DW, Frizzera G, Gajl-Peczalska KJ, Sakamoto K, Purtilo DT, Balfour HH, Jr, Simmons RL, Najarian JS. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med. 1982 Apr 15;306(15):913–918. [PubMed] [Google Scholar]\n\nHanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res. 1981 Nov;41(11 Pt 1):4253–4261. [PubMed] [Google Scholar]\n\nHaramati LB, Schulman LL, Austin JH. Lung nodules and masses after cardiac transplantation. Radiology. 1993 Aug;188(2):491–497. [PubMed] [Google Scholar]\n\nHarbison MA, De Girolami PC, Jenkins RL, Hammer SM. Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients. Transplantation. 1988 Jul;46(1):82–88. [PubMed] [Google Scholar]\n\nHardy AM, Wajszczuk CP, Suffredini AF, Hakala TR, Ho M. Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids. J Infect Dis. 1984 Feb;149(2):143–147. [PubMed] [Google Scholar]\n\nHarland RC, Vernon WB, Bunzendahl H, Thompson JK, Lawrence C, Bollinger RR. Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients. Transplant Proc. 1994 Apr;26(2):432–433. [PubMed] [Google Scholar]\n\nHarris LF, Dan BM, Lefkowitz LB, Jr, Alford RH. Paecilomyces cellulitis in a renal transplant patient: successful treatment with intravenous miconazole. South Med J. 1979 Jul;72(7):897–898. [PubMed] [Google Scholar]\n\nHavel MP, Laczkovics AM, Wolner E, Kurz RW, Popow-Kraupp T. Prophylactic use of hyperimmunoglobulin for cytomegalovirus infection in heart transplantation. Clin Ther. 1989 Jul-Aug;11(4):472–478. [PubMed] [Google Scholar]\n\nHayes MJ, Torzillo PJ, Sheil AG, McCaughan GW. Pneumocystis carinii pneumonia after liver transplantation in adults. Clin Transplant. 1994 Dec;8(6):499–503. [PubMed] [Google Scholar]\n\nHeaton A, Arze RS, Ward MK. Acyclovir for life-threatening herpes simplex virus infection after renal transplantation. Lancet. 1981 Oct 17;2(8251):875–875. [PubMed] [Google Scholar]\n\nHeironimus JD, Winn RE, Collins CB. Cutaneous nonpulmonary Mycobacterium chelonei infection. Successful treatment with sulfonamides in an immunosuppressed patient. Arch Dermatol. 1984 Aug;120(8):1061–1063. [PubMed] [Google Scholar]\n\nHellman RN, Hinrichs J, Sicard G, Hoover R, Golden P, Hoffsten P. Cryptococcal pyelonephritis and disseminated cryptococcosis in a renal transplant recipient. Arch Intern Med. 1981 Jan;141(1):128–130. [PubMed] [Google Scholar]\n\nHenriquez M, Levy R, Raja RM, Kramer MS, Rosenbaum JL. Mucormycosis in a renal transplant recipient with successful outcome. JAMA. 1979 Sep 28;242(13):1397–1399. [PubMed] [Google Scholar]\n\nHesse UJ, Sutherland DE, Simmons RL, Najarian JS. Intra-abdominal infections in pancreas transplant recipients. Ann Surg. 1986 Feb;203(2):153–162. [PMC free article] [PubMed] [Google Scholar]\n\nHibberd PL, Rubin RH. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis. 1994 Aug;19 (Suppl 1):S33–S40. [PubMed] [Google Scholar]\n\nHibberd PL, Tolkoff-Rubin NE, Conti D, Stuart F, Thistlethwaite JR, Neylan JF, Snydman DR, Freeman R, Lorber MI, Rubin RH. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med. 1995 Jul 1;123(1):18–26. [PubMed] [Google Scholar]\n\nHibberd PL, Tolkoff-Rubin NE, Cosimi AB, Schooley RT, Isaacson D, Doran M, Delvecchio A, Delmonico FL, Auchincloss H, Jr, Rubin RH. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation. 1992 Jan;53(1):68–72. [PubMed] [Google Scholar]\n\nHiggins RM, Bloom SL, Hopkin JM, Morris PJ. The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation. Transplantation. 1989 Mar;47(3):558–560. [PubMed] [Google Scholar]\n\nHiggins RM, Cahn AP, Porter D, Richardson AJ, Mitchell RG, Hopkin JM, Morris PJ. Mycobacterial infections after renal transplantation. Q J Med. 1991 Feb;78(286):145–153. [PubMed] [Google Scholar]\n\nHii JH, Legault L, DeVeber G, Vas SI. Successful treatment of systemic blastomycosis with high-dose ketoconazole in a renal transplant recipient. Am J Kidney Dis. 1990 Jun;15(6):595–597. [PubMed] [Google Scholar]\n\nHirsch MS, Schooley RT, Cosimi AB, Russell PS, Delmonico FL, Tolkoff-Rubin NE, Herrin JT, Cantell K, Farrell ML, Rota TR, et al. Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients. N Engl J Med. 1983 Jun 23;308(25):1489–1493. [PubMed] [Google Scholar]\n\nHirschl MM, Derfler K, Janata O, Heinz G, Sertl K, Balcke P. Accumulation of pneumocystis carinii pneumonia in patients after kidney transplantation. Clin Nephrol. 1992 Feb;37(2):105–105. [PubMed] [Google Scholar]\n\nHirschmann JV, Plorde JJ, Ochi RF. Fever and pulmonary infiltrates in a patient with a renal transplant. West J Med. 1984 Jun;140(6):914–920. [PMC free article] [PubMed] [Google Scholar]\n\nHo M. Advances in understanding cytomegalovirus infection after transplantation. Transplant Proc. 1994 Oct;26(5 Suppl 1):7–11. [PubMed] [Google Scholar]\n\nHoepelman IM, Bakker LJ, Jessurun RF, Rozenberg-Arska M, Verhoef J. Disseminated Nocardia asteroides infection complicating renal transplantation. Neth J Med. 1987 Oct;31(3-4):175–182. [PubMed] [Google Scholar]\n\nHofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med. 1987 Feb;106(2):209–216. [PubMed] [Google Scholar]\n\nHolden FA, Kaczmer JE, Kinahan CC. Listerial meningitis and renal allografts: a life-threatening affinity. Postgrad Med. 1980 Dec;68(6):69–74. [PubMed] [Google Scholar]\n\nHoon V, Fasy TM, Kheiri S, Theise N, Lin CS, Klion F, Schwartz M, Miller C, Thung SN. Case report: fatal lymphoproliferative disease seven weeks after liver transplantation. Mt Sinai J Med. 1994 Jan;61(1):72–76. [PubMed] [Google Scholar]\n\nHOPE-SIMPSON RE. THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. Proc R Soc Med. 1965 Jan;58:9–20. [PMC free article] [PubMed] [Google Scholar]\n\nHopt UT, Pfeffer F, Schareck W, Büsing M, Ming C. Ganciclovir for prophylaxis of CMV disease after pancreas/kidney transplantation. Transplant Proc. 1994 Apr;26(2):434–435. [PubMed] [Google Scholar]\n\nHornef MW, Bein G, Fricke L, Steinhoff J, Wagner HJ, Hinderer W, Sonneborn HH, Kirchner H. Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients. Transplantation. 1995 Sep 15;60(5):474–480. [PubMed] [Google Scholar]\n\nHorton CM, Freeman CD, Nolan PE, Jr, Copeland JG., 3rd Cyclosporine interactions with miconazole and other azole-antimycotics: a case report and review of the literature. J Heart Lung Transplant. 1992 Nov-Dec;11(6):1127–1132. [PubMed] [Google Scholar]\n\nHorvath J, Dummer S, Loyd J, Walker B, Merrill WH, Frist WH. Infection in the transplanted and native lung after single lung transplantation. Chest. 1993 Sep;104(3):681–685. [PubMed] [Google Scholar]\n\nHoward RJ, Simmons RL, Najarian JS. Fungal infections in renal transplant recipients. Ann Surg. 1978 Nov;188(5):598–605. [PMC free article] [PubMed] [Google Scholar]\n\nHoy WE, Roberts NJ, Jr, Bryson MF, Bowles C, Lee JC, Rivero AJ, Ritterson AL. Transmission of strongyloidiasis by kidney transplant? Disseminated strongyloidiasis in both recipients of kidney allografts from a single cadaver donor. JAMA. 1981 Oct 23;246(17):1937–1939. [PubMed] [Google Scholar]\n\nHrebinko R, Jordan ML, Dummer JS, Hickey DP, Shapiro R, Vivas C, Starzl TE, Simmons RL, Hakala TR. Ganciclovir for invasive cytomegalovirus infection in renal allograft recipients. Transplant Proc. 1991 Feb;23(1 Pt 2):1346–1347. [PMC free article] [PubMed] [Google Scholar]\n\nHuang JY, Huang CC, Lai MK, Chu SH, Chuang CK. Salmonella infection in renal transplant recipients. Transplant Proc. 1994 Aug;26(4):2147–2147. [PubMed] [Google Scholar]\n\nHubscher SG, Buckels JA, Elias E, McMaster P, Neuberger J. Vanishing bile-duct syndrome following liver transplantation--is it reversible? Transplantation. 1991 May;51(5):1004–1010. [PubMed] [Google Scholar]\n\nHubscher SG, Williams A, Davison SM, Young LS, Niedobitek G. Epstein-Barr virus in inflammatory diseases of the liver and liver allografts: an in situ hybridization study. Hepatology. 1994 Oct;20(4 Pt 1):899–907. [PubMed] [Google Scholar]\n\nHummel M, Schüler S, Hempel S, Rees W, Hetzer R. Obstructive bronchial aspergillosis after heart transplantation. Mycoses. 1993 Nov-Dec;36(11-12):425–428. [PubMed] [Google Scholar]\n\nHummel M, Schüler S, Weber U, Schwertlick G, Hempel S, Theiss D, Rees W, Mueller J, Hetzer R. Aspergillosis with Aspergillus osteomyelitis and diskitis after heart transplantation: surgical and medical management. J Heart Lung Transplant. 1993 Jul-Aug;12(4):599–603. [PubMed] [Google Scholar]\n\nHummel M, Thalmann U, Jautzke G, Staib F, Seibold M, Hetzer R. Fungal infections following heart transplantation. Mycoses. 1992 Jan-Feb;35(1-2):23–34. [PubMed] [Google Scholar]\n\nHumphreys H, Marshall RJ, Mackay I, Caul EO. Pneumonia due to Legionella bozemanii and Chlamydia psittaci/TWAR following renal transplantation. J Infect. 1992 Jul;25(1):67–71. [PubMed] [Google Scholar]\n\nIacobellis FW, Jacobs MI, Cohen RP. Primary cutaneous cryptococcosis. Arch Dermatol. 1979 Aug;115(8):984–985. [PubMed] [Google Scholar]\n\nIberer F, Halwachs-Baumann G, Rödl S, Pleisnitzer A, Wasler A, Auer T, Petutschnigg B, Müller H, Tscheliessnigg K, Wilders-Truschnig M. Monitoring of cytomegalovirus disease after heart transplantation: persistence of anti-cytomegalovirus IgM antibodies. J Heart Lung Transplant. 1994 May-Jun;13(3):405–411. [PubMed] [Google Scholar]\n\nIcenogle TB, Peterson E, Ray G, Minnich L, Copeland JG. DHPG effectively treats CMV infection in heart and heart-lung transplant patients: a preliminary report. J Heart Transplant. 1987 Jul-Aug;6(4):199–203. [PubMed] [Google Scholar]\n\nIndudhara R, Singh SK, Minz M, Yadav RV, Chugh KS. Tuberculous pyomyositis in a renal transplant recipient. Tuber Lung Dis. 1992 Aug;73(4):239–241. [PubMed] [Google Scholar]\n\nIngwer I, McLeish KR, Tight RR, White AC. Aspergillus fumigatus epidural abscess in a renal transplant recipient. Arch Intern Med. 1978 Jan;138(1):153–154. [PubMed] [Google Scholar]\n\nIreton RC, Krieger JN, Rudd TG, Marchioro TL. Percutaneous endoscopic treatment of fungus ball obstruction in a renal allograft. Transplantation. 1985 Apr;39(4):453–454. [PubMed] [Google Scholar]\n\nJaccard A, Emile JF, Metivier F, Clauvel JP, d'Agay MF. Epstein-Barr virus-associated Hodgkin's disease following renal transplantation. Am J Hematol. 1994 Jul;46(3):256–257. [PubMed] [Google Scholar]\n\nJacobs F, Byl B, Bourgeois N, Coremans-Pelseneer J, Florquin S, Depré G, Van de Stadt J, Adler M, Gelin M, Thys JP. Trichoderma viride infection in a liver transplant recipient. Mycoses. 1992 Nov-Dec;35(11-12):301–303. [PubMed] [Google Scholar]\n\nJacobs F, Van de Stadt J, Gelin M, Nonhoff C, Gay F, Adler M, Thys JP. Mycoplasma hominis infection of perihepatic hematomas in a liver transplant recipient. Surgery. 1992 Jan;111(1):98–100. [PubMed] [Google Scholar]\n\nJacobs F, Van de Stadt J, Bourgeois N, Struelens MJ, De Prez C, Adler M, Thys JP, Gelin M. Severe infections early after liver transplantation. Transplant Proc. 1989 Feb;21(1 Pt 2):2271–2273. [PubMed] [Google Scholar]\n\nJamieson SW, Stinson EB, Oyer PE, Reitz BA, Baldwin J, Modry D, Dawkins K, Theodore J, Hunt S, Shumway NE. Heart-lung transplantation for irreversible pulmonary hypertension. Ann Thorac Surg. 1984 Dec;38(6):554–562. [PubMed] [Google Scholar]\n\nJanner D, Bork J, Baum M, Chinnock R. Severe pneumonia after heart transplantation as a result of human parvovirus B19. J Heart Lung Transplant. 1994 Mar-Apr;13(2):336–338. [PubMed] [Google Scholar]\n\nJennings HS, 3rd, Bradsher RW, McGee ZA, Johnson HK, Alford RH. Acute cryptococcal cellulitis in renal transplant recipients. South Med J. 1981 Sep;74(9):1150–1153. [PubMed] [Google Scholar]\n\nJensen WA, Rose RM, Hammer SM, Jenkins RL, Bothe A, Jr, Benotti PN, Dzik WH, Costello P, Khettry U, Trey C, et al. Pulmonary complications of orthotopic liver transplantation. Transplantation. 1986 Nov;42(5):484–490. [PubMed] [Google Scholar]\n\nJernigan DB, Sanders LI, Waites KB, Brookings ES, Benson RF, Pappas PG. Pulmonary infection due to Legionella cincinnatiensis in renal transplant recipients: two cases and implications for laboratory diagnosis. Clin Infect Dis. 1994 Mar;18(3):385–389. [PubMed] [Google Scholar]\n\nJohnson BL. Intraocular and central nervous system lymphoma in a cardiac transplant recipient. Ophthalmology. 1992 Jun;99(6):987–992. [PubMed] [Google Scholar]\n\nJordan ML, Hrebinko RL, Jr, Dummer JS, Hickey DP, Shapiro R, Vivas CA, Simmons RL, Starzl TE, Hakala TR. Therapeutic use of ganciclovir for invasive cytomegalovirus infection in cadaveric renal allograft recipients. J Urol. 1992 Nov;148(5):1388–1392. [PMC free article] [PubMed] [Google Scholar]\n\nJoshi SN, Garvin PJ, Sunwoo YC. Candidiasis of the duodenum and jejunum. Gastroenterology. 1981 Apr;80(4):829–833. [PubMed] [Google Scholar]\n\nKaden J, Scholz D, Eichler C, May G. Infektionshäufigkeit mit Zytomegalieviren (CMV) nach Nierentransplantation und erste Erfahrungen mit der CMV-Gammaglobulinprophylaxe. Immun Infekt. 1985 Nov;13(6):290–295. [PubMed] [Google Scholar]\n\nKaplan AH, Poza-Juncal E, Shapiro R, Stapleton JT. Cure of mucormycosis in a renal transplant patient receiving ciclosporin with maintenance of immunosuppression. Am J Nephrol. 1988;8(2):139–142. [PubMed] [Google Scholar]\n\nKaplan JE, Zoschke D, Kisch AL. Withdrawal of immunosuppresive agents in the treatment of disseminated coccidioidomycosis. Am J Med. 1980 Apr;68(4):624–628. [PubMed] [Google Scholar]\n\nKasiske BL, Heim-Duthoy KL, Tortorice KL, Ney AL, Odland MD, Rao KV. Polyvalent immune globulin and cytomegalovirus infection after renal transplantation. Arch Intern Med. 1989 Dec;149(12):2733–2736. [PubMed] [Google Scholar]\n\nKatz NM, Pierce PF, Anzeck RA, Visner MS, Canter HG, Foegh ML, Pearle DL, Tracy C, Rahman A. Liposomal amphotericin B for treatment of pulmonary aspergillosis in a heart transplant patient. J Heart Transplant. 1990 Jan-Feb;9(1):14–17. [PubMed] [Google Scholar]\n\nKeane WM, Potsic WP, Perloff LJ, Barker CF, Grossman RA. Aspergillus thyroiditis. Otolaryngology. 1978 Sep-Oct;86(5):ORL–761-5. [PubMed] [Google Scholar]\n\nKeating MR. Antiviral agents. Mayo Clin Proc. 1992 Feb;67(2):160–178. [PubMed] [Google Scholar]\n\nKeay S, Petersen E, Icenogle T, Zeluff BJ, Samo T, Busch D, Newman CL, Buhles WC, Jr, Merigan TC. Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 3):S563–S572. [PubMed] [Google Scholar]\n\nKeenan RJ, Konishi H, Kawai A, Paradis IL, Nunley DR, Iacono AT, Hardesty RL, Weyant RJ, Griffith BP. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg. 1995 Sep;60(3):580–585. [PubMed] [Google Scholar]\n\nKendall TJ, Wilson JE, Radio SJ, Kandolf R, Gulizia JM, Winters GL, Costanzo-Nordin MR, Malcom GT, Thieszen SL, Miller LW, et al. Cytomegalovirus and other herpesviruses: do they have a role in the development of accelerated coronary arterial disease in human heart allografts? J Heart Lung Transplant. 1992 May-Jun;11(3 Pt 2):S14–S20. [PubMed] [Google Scholar]\n\nKhawand N, Light JA, Brems W, Aquino A, Ali A. Does intravenous immunoglobulin prevent primary cytomegalovirus disease in kidney transplant recipients? Transplant Proc. 1989 Feb;21(1 Pt 2):2072–2074. [PubMed] [Google Scholar]\n\nKim JH, Perfect JR. Infection and cyclosporine. Rev Infect Dis. 1989 Sep-Oct;11(5):677–690. [PubMed] [Google Scholar]\n\nKinder RB, Jourdan MH. Disseminated aspergillosis and bleeding colonic ulcers in renal transplant patient. J R Soc Med. 1985 Apr;78(4):338–339. [PMC free article] [PubMed] [Google Scholar]\n\nKing D, Pasarell L, Dixon DM, McGinnis MR, Merz WG. A phaeohyphomycotic cyst and peritonitis caused by Phialemonium species and a reevaluation of its taxonomy. J Clin Microbiol. 1993 Jul;31(7):1804–1810. [PMC free article] [PubMed] [Google Scholar]\n\nKirchhoff LV. American trypanosomiasis (Chagas' disease)--a tropical disease now in the United States. N Engl J Med. 1993 Aug 26;329(9):639–644. [PubMed] [Google Scholar]\n\nKirklin JK, Naftel DC, Levine TB, Bourge RC, Pelletier GB, O'Donnell J, Miller LW, Pritzker MR. Cytomegalovirus after heart transplantation. Risk factors for infection and death: a multiinstitutional study. The Cardiac Transplant Research Database Group. J Heart Lung Transplant. 1994 May-Jun;13(3):394–404. [PubMed] [Google Scholar]\n\nKish LS, Taylor JS, Bergfeld WF, Hall GS. Petriellidium (Allescheria) boydii mycetoma in an immunosuppressed host. Cleve Clin Q. 1983 Summer;50(2):209–211. [PubMed] [Google Scholar]\n\nKitai IC, King S, Gafni A. An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients. Clin Infect Dis. 1993 Sep;17(3):441–447. [PubMed] [Google Scholar]\n\nKiyasu PK, Ishitani MB, McGory RW, Gaffey MJ, Dickson RC, Caldwell SH, Stevenson WS, Pruett TL. Prevention of hepatitis B \"rerecurrence\" after a second liver transplant--the role of maintenance polyclonal HBIG therapy. Transplantation. 1994 Oct 27;58(8):954–956. [PubMed] [Google Scholar]\n\nKizilisik TA, Preiksaitis JK, Kneteman NM. Cytomegalovirus disease in liver transplant recipients: impact of acyclovir prophylaxis. Transplant Proc. 1993 Jun;25(3):2282–2283. [PubMed] [Google Scholar]\n\nKlintmalm G, Lönnqvist B, Oberg B, Gahrton G, Lernestedt JO, Lundgren G, Ringdén O, Robert KH, Wahren B, Groth CG. Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients. Scand J Infect Dis. 1985;17(2):157–163. [PubMed] [Google Scholar]\n\nKochhar R, Indudhara R, Nagi B, Yadav RV, Mehta SK. Colonic tuberculosis due to atypical mycobacteria in a renal transplant recipient. Am J Gastroenterol. 1988 Dec;83(12):1435–1436. [PubMed] [Google Scholar]\n\nKoizumi JH, Sommers HM. Mycobacterium xenopi and pulmonary disease. Am J Clin Pathol. 1980 Jun;73(6):826–830. [PubMed] [Google Scholar]\n\nKolbeck PC, Makhoul RG, Bollinger RR, Sanfilippo F. Widely disseminated Cunninghamella mucormycosis in an adult renal transplant patient: case report and review of the literature. Am J Clin Pathol. 1985 Jun;83(6):747–753. [PubMed] [Google Scholar]\n\nKong NC, Shaariah W, Morad Z, Suleiman AB, Wong YH. Cryptococcosis in a renal unit. Aust N Z J Med. 1990 Oct;20(5):645–649. [PubMed] [Google Scholar]\n\nKoranda FC, Dehmel EM, Kahn G, Penn I. Cutaneous complications in immunosuppressed renal homograft recipients. JAMA. 1974 Jul 22;229(4):419–424. [PubMed] [Google Scholar]\n\nKorvick J, Yu VL. Simultaneous infection with Cryptococcus neoformans and Legionella pneumophila. In vivo expression of common defects in cell-mediated immunity. Respiration. 1988;53(2):132–136. [PubMed] [Google Scholar]\n\nKorvick JA, Marsh JW, Starzl TE, Yu VL. Pseudomonas aeruginosa bacteremia in patients undergoing liver transplantation: an emerging problem. Surgery. 1991 Jan;109(1):62–68. [PMC free article] [PubMed] [Google Scholar]\n\nKovacs JA, Ng VL, Masur H, Leoung G, Hadley WK, Evans G, Lane HC, Ognibene FP, Shelhamer J, Parrillo JE, et al. Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Engl J Med. 1988 Mar 10;318(10):589–593. [PubMed] [Google Scholar]\n\nKovarik J, Mayer G, Pohanka E, Schwarz M, Traindl O, Graf H, Smolen J. Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections. Transplantation. 1988 Feb;45(2):402–405. [PubMed] [Google Scholar]\n\nKramer MR, Marshall SE, Denning DW, Keogh AM, Tucker RM, Galgiani JN, Lewiston NJ, Stevens DA, Theodore J. Cyclosporine and itraconazole interaction in heart and lung transplant recipients. Ann Intern Med. 1990 Aug 15;113(4):327–329. [PubMed] [Google Scholar]\n\nKramer MR, Denning DW, Marshall SE, Ross DJ, Berry G, Lewiston NJ, Stevens DA, Theodore J. Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):552–556. [PubMed] [Google Scholar]\n\nKramer MR, Marshall SE, Starnes VA, Gamberg P, Amitai Z, Theodore J. Infectious complications in heart-lung transplantation. Analysis of 200 episodes. Arch Intern Med. 1993 Sep 13;153(17):2010–2016. [PubMed] [Google Scholar]\n\nKramer MR, Stoehr C, Lewiston NJ, Starnes VA, Theodore J. Trimethoprim-sulfamethoxazole prophylaxis for Pneumocystis carinii infections in heart-lung and lung transplantation--how effective and for how long? Transplantation. 1992 Mar;53(3):586–589. [PubMed] [Google Scholar]\n\nKramer P, ten Kate FW, Bijnen AB, Jeekel J, Weimar W. Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients. Lancet. 1984 May 5;1(8384):989–990. [PubMed] [Google Scholar]\n\nKramer P, Prins ME, Kapsenberg JG, Bornkamm GW, Bijnen AB, Rohol PJ, van der Heul RO, Jeekel J, Weimar W. Persistent Epstein-Barr virus infection and a histiocytic sarcoma in a renal transplant recipient. Cancer. 1985 Feb 1;55(3):503–509. [PubMed] [Google Scholar]\n\nKrom RA, Kingma LM, Haagsma EB, Wesenhagen H, Slooff MJ, Gips CH. Choledochocholedochostomy, a relatively safe procedure in orthotopic liver transplantation. Surgery. 1985 May;97(5):552–556. [PubMed] [Google Scholar]\n\nKumar P, Pearson JE, Martin DH, Leech SH, Buisseret PD, Bezbak HC, Gonzalez FM, Royer JR, Streicher HZ, Saxinger WC. Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome. Ann Intern Med. 1987 Feb;106(2):244–245. [PubMed] [Google Scholar]\n\nKumar S, Trivedi HL, Smith EK. Letter: Rhinocerebral mucormycosis in a renal transplant patient. J Oral Surg. 1976 Jul;34(7):583–583. [PubMed] [Google Scholar]\n\nKusne S, Dummer JS, Singh N, Iwatsuki S, Makowka L, Esquivel C, Tzakis AG, Starzl TE, Ho M. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 1988 Mar;67(2):132–143. [PMC free article] [PubMed] [Google Scholar]\n\nKusne S, Schwartz M, Breinig MK, Dummer JS, Lee RE, Selby R, Starzl TE, Simmons RL, Ho M. Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis. 1991 May;163(5):1001–1007. [PMC free article] [PubMed] [Google Scholar]\n\nKusne S, Tobin D, Pasculle AW, Van Thiel DH, Ho M, Starzl TE. Candida carriage in the alimentary tract of liver transplant candidates. Transplantation. 1994 Feb;57(3):398–402. [PMC free article] [PubMed] [Google Scholar]\n\nKusne S, Torre-Cisneros J, Mañez R, Irish W, Martin M, Fung J, Simmons RL, Starzl TE. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis. 1992 Dec;166(6):1379–1383. [PMC free article] [PubMed] [Google Scholar]\n\nLaghi F, Yeldandi V, McCabe M, Garrity ER., Jr Common infections complicating lung transplantation. N J Med. 1993 Apr;90(4):317–319. [PubMed] [Google Scholar]\n\nLakshiminarayan S, Sahn SA. Tuberculosis in a patient after renal transplantation. Tubercle. 1973 Mar;54(1):72–76. [PubMed] [Google Scholar]\n\nLang P, Buisson C, Rostoker G, Ben Maadi A, Fruchaud G, Deforge L, Chopin D, Abbou C, Romano P, Fleury J, et al. DHPG treatment of kidney transplant recipients with severe CMV infection. Transplant Proc. 1989 Feb;21(1 Pt 2):2084–2086. [PubMed] [Google Scholar]\n\nLanghoff E, Madsen S. Rapid metabolism of cyclosporin and prednisone in kidney transplant patients on tuberculostatic treatment. Lancet. 1983 Dec 3;2(8362):1303–1303. [PubMed] [Google Scholar]\n\nLanglois RP, Flegel KM, Meakins JL, Morehouse DD, Robson HG, Guttmann RD. Cutaneous aspergillosis with fatal dissemination in a renal transplant recipient. Can Med Assoc J. 1980 Mar 22;122(6):673–676. [PMC free article] [PubMed] [Google Scholar]\n\nLangnas AN, Markin RS, Cattral MS, Naides SJ. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology. 1995 Dec;22(6):1661–1665. [PubMed] [Google Scholar]\n\nLaske A, Gallino A, Mohacsi P, Bauer EP, Carrel T, von Segesser LK, Turina MI. Prophylactic treatment with ganciclovir for cytomegalovirus infection in heart transplantation. Transplant Proc. 1991 Feb;23(1 Pt 2):1170–1173. [PubMed] [Google Scholar]\n\nLautenschlager I, Ahonen J, Eklund B, Höckerstedt K, Salmela K, Isoniemi H, Korsbäck C, Suni J, Häyry P. Hyperimmune globulin therapy of clinical CMV disease in renal allograft recipients. Transplant Proc. 1989 Feb;21(1 Pt 2):2087–2088. [PubMed] [Google Scholar]\n\nLazarovits AI, Tibbles LA, Grant DR, Ghent CN, Wall WJ, White MJ, Joncas JH. Anti-B cell antibodies for the treatment of monoclonal Epstein-Barr virus-induced lymphoproliferative syndrome after multivisceral transplantation. Clin Invest Med. 1994 Dec;17(6):621–625. [PubMed] [Google Scholar]\n\nLeapman SB, Rosenberg JB, Filo RS, Smith EJ. Strongyloides stercoralis in chronic renal failure: safe therapy with thiabendazole. South Med J. 1980 Oct;73(10):1400–1402. [PubMed] [Google Scholar]\n\nLecatsas G. Papillomavirus in urine in pregnancy and following renal transplantation. Prog Clin Biol Res. 1983;105:143–148. [PubMed] [Google Scholar]\n\nLe Conte P, Blanloeil Y, Michel P, Francois T, Paineau J. Cutaneous aspergillosis in a patient with orthotopic hepatic transplantation. Transplantation. 1992 May;53(5):1153–1154. [PubMed] [Google Scholar]\n\nLee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, Nour B, Tzakis A, Dickman PS. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med. 1995 Jan 5;332(1):19–25. [PubMed] [Google Scholar]\n\nLee JY. Cytomegalovirus infection involving the skin in immunocompromised hosts. A clinicopathologic study. Am J Clin Pathol. 1989 Jul;92(1):96–100. [PubMed] [Google Scholar]\n\nLeff RD, Smith EJ, Aldo-Benson MA, Aronoff GR. Cryptococcal arthritis after renal transplantation. South Med J. 1981 Oct;74(10):1290–1290. [PubMed] [Google Scholar]\n\nLegendre C, Ducloux D, Ferroni A, Chkoff N, Valette C, Geffrier C, Rouzioux C, Kreis H. Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: a case-controlled study. Transplant Proc. 1993 Feb;25(1 Pt 2):1431–1433. [PubMed] [Google Scholar]\n\nLeiguarda R, Roncoroni A, Taratuto AL, Jost L, Berthier M, Nogues M, Freilij H. Acute CNS infection by Trypanosoma cruzi (Chagas' disease) in immunosuppressed patients. Neurology. 1990 May;40(5):850–851. [PubMed] [Google Scholar]\n\nLe Saux NM, Sekla L, McLeod J, Parker S, Rush D, Jeffery JR, Brunham RC. Epidemic of nosocomial Legionnaires' disease in renal transplant recipients: a case-control and environmental study. CMAJ. 1989 May 1;140(9):1047–1053. [PMC free article] [PubMed] [Google Scholar]\n\nLibow LF, Beltrani VP, Silvers DN, Grossman ME. Post-cardiac transplant reactivation of Chagas' disease diagnosed by skin biopsy. Cutis. 1991 Jul;48(1):37–40. [PubMed] [Google Scholar]\n\nLichtenstein IH, MacGregor RR. Mycobacterial infections in renal transplant recipients: report of five cases and review of the literature. Rev Infect Dis. 1983 Mar-Apr;5(2):216–226. [PubMed] [Google Scholar]\n\nLinnemann CC, Jr, First MR, Schiffman G. Response to pneumococcal vaccine in renal transplant and hemodialysis patients. Arch Intern Med. 1981 Nov;141(12):1637–1640. [PubMed] [Google Scholar]\n\nLipman MC, Pillay D, Squire SB, Sweny P, Johnson MA. HIV infection in a long-term renal transplant recipient. Int J STD AIDS. 1995 Mar-Apr;6(2):121–122. [PubMed] [Google Scholar]\n\nLivas IC, Nechay PS, Nauseef WM. Clinical evidence of spinal and cerebral histoplasmosis twenty years after renal transplantation. Clin Infect Dis. 1995 Mar;20(3):692–695. [PubMed] [Google Scholar]\n\nLloveras J, Peterson PK, Simmons RL, Najarian JS. Mycobacterial infections in renal transplant recipients. Seven cases and a review of the literature. Arch Intern Med. 1982 May;142(5):888–892. [PubMed] [Google Scholar]\n\nLocke TJ, Odom NJ, Tapson JS, Freeman R, McGregor CG. Successful treatment with trisodium phosphonoformate for primary cytomegalovirus infection after heart transplantation. J Heart Transplant. 1987 Mar-Apr;6(2):120–122. [PubMed] [Google Scholar]\n\nLones MA, Mishalani S, Shintaku IP, Weiss LM, Nichols WS, Said JW. Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring. Hum Pathol. 1995 May;26(5):525–530. [PubMed] [Google Scholar]\n\nLoria KM, Salinger MH, Frohlich TG, Gendelman MD, Cook FV, Arentzen CE. Primary cutaneous aspergillosis in a heart transplant recipient treated with surgical excision and oral itraconazole. J Heart Lung Transplant. 1992 Jan-Feb;11(1 Pt 1):156–159. [PubMed] [Google Scholar]\n\nLuby JP, Ramirez-Ronda C, Rinner S, Hull A, Vergne-Marini P. A longitudinal study of varicella-zoster virus infections in renal transplant recipients. J Infect Dis. 1977 Apr;135(4):659–663. [PubMed] [Google Scholar]\n\nLugo-Janer GJ, Pedraza R, Morales Otero LA, González ZA, Muñiz A, Sánchez J, Santiago-Delpín EA. Superficial mycosis in renal transplant recipients. Transplant Proc. 1991 Apr;23(2):1787–1788. [PubMed] [Google Scholar]\n\nLui SF, Ali AA, Grundy JE, Fernando ON, Griffiths PD, Sweny P. Double-blind, placebo-controlled trial of human lymphoblastoid interferon prophylaxis of cytomegalovirus infection in renal transplant recipients. Nephrol Dial Transplant. 1992;7(12):1230–1237. [PubMed] [Google Scholar]\n\nLumbreras C, Fernandez I, Velosa J, Munn S, Sterioff S, Paya CV. Infectious complications following pancreatic transplantation: incidence, microbiological and clinical characteristics, and outcome. Clin Infect Dis. 1995 Mar;20(3):514–520. [PubMed] [Google Scholar]\n\nLumbreras C, Lizasoain M, Moreno E, Aguado JM, Gomez R, Garcia I, Gonzalez I, Loinaz C, Cisneros C, Noriega AR. Major bacterial infections following liver transplantation: a prospective study. Hepatogastroenterology. 1992 Aug;39(4):362–365. [PubMed] [Google Scholar]\n\nLumbreras C, Otero JR, Herrero JA, Gomez R, Lizasoain M, Aguado JM, Colina F, Garcia I, Moreno E, Noriega AR. Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies. Antimicrob Agents Chemother. 1993 Nov;37(11):2490–2492. [PMC free article] [PubMed] [Google Scholar]\n\nLynfield R, Herrin JT, Rubin RH. Varicella in pediatric renal transplant recipients. Pediatrics. 1992 Aug;90(2 Pt 1):216–220. [PubMed] [Google Scholar]\n\nMacDonald AS, Belitsky P, Cohen A, Lee S. Cytomegalovirus disease prophylaxis in seronegative recipients of kidneys from seropositive donors by combination of cytomegalovirus-hyperimmune globulin and low-dose acyclovir. Transplant Proc. 1991 Feb;23(1 Pt 2):1355–1356. [PubMed] [Google Scholar]\n\nMai M, Nery J, Sutker W, Husberg B, Klintmalm G, Gonwa T. DHPG (Gancyclovir) improves survival in CMV pneumonia. Transplant Proc. 1989 Feb;21(1 Pt 2):2263–2265. [PubMed] [Google Scholar]\n\nMaki DG, Fox BC, Kuntz J, Sollinger HW, Belzer FO. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine. J Lab Clin Med. 1992 Jan;119(1):11–24. [PubMed] [Google Scholar]\n\nMancini MC, McGinnis MR. Dactylaria infection of a human being: pulmonary disease in a heart transplant recipient. J Heart Lung Transplant. 1992 Jul-Aug;11(4 Pt 1):827–830. [PubMed] [Google Scholar]\n\nMaple PA, McKee T, Desselberger U, Wreghitt TG. Hepatitis C virus infections in transplant patients: serological and virological investigations. J Med Virol. 1994 Sep;44(1):43–48. [PubMed] [Google Scholar]\n\nMarchevsky AM, Bottone EJ, Geller SA, Giger DK. The changing spectrum of disease, etiology, and diagnosis of mucormycosis. Hum Pathol. 1980 Sep;11(5):457–464. [PubMed] [Google Scholar]\n\nMarker SC, Simmons RL, Balfour HH., Jr Cytomegalovirus vaccine in renal allograft recipients. Transplant Proc. 1981 Mar;13(1 Pt 1):117–119. [PubMed] [Google Scholar]\n\nMarkin RS, Langnas AN, Donovan JP, Zetterman RK, Stratta RJ. Opportunistic viral hepatitis in liver transplant recipients. Transplant Proc. 1991 Feb;23(1 Pt 2):1520–1521. [PubMed] [Google Scholar]\n\nMartin M, Mañez R, Linden P, Estores D, Torre-Cisneros J, Kusne S, Ondick L, Ptachcinski R, Irish W, Kisor D, et al. A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation. 1994 Oct 15;58(7):779–785. [PMC free article] [PubMed] [Google Scholar]\n\nMartin M, Kusne S, Alessiani M, Simmons R, Starzl TE. Infections after liver transplantation: risk factors and prevention. Transplant Proc. 1991 Jun;23(3):1929–1930. [PMC free article] [PubMed] [Google Scholar]\n\nMartin-Santos JM, Alonso-Pulpon L, Pradas G, Cuervas-Mons V, Anguita M, Mulero-Mendoza J, Escribano E, Martinez-Beltran J, Figuera-Aymerich D. Septic arthritis by Salmonella enteritidis after heart transplantation. J Heart Transplant. 1987 May-Jun;6(3):177–179. [PubMed] [Google Scholar]\n\nMartineau G, Porter KA, Corman J, Launois B, Schroter GT, Palmer W, Putnam CW, Groth CG, Halgrimson CG, Penn I, et al. Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery. 1972 Oct;72(4):604–610. [PMC free article] [PubMed] [Google Scholar]\n\nMartinez AJ, Ahdab-Barmada M. The neuropathology of liver transplantation: comparison of main complications in children and adults. Mod Pathol. 1993 Jan;6(1):25–32. [PubMed] [Google Scholar]\n\nMarzano A, Smedile A, Abate M, Ottobrelli A, Brunetto M, Negro F, Farci P, Durazzo M, David E, Lagget M, et al. Hepatitis type C after orthotopic liver transplantation: reinfection and disease recurrence. J Hepatol. 1994 Dec;21(6):961–965. [PubMed] [Google Scholar]\n\nMauch TJ, Crouch NA, Freese DK, Braunlin EA, Dunn DL, Kashtan CE. Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr. 1995 Dec;127(6):957–960. [PubMed] [Google Scholar]\n\nMaurer JR, Snell G, deHoyos A, Kesten S, Winton T. Outcomes of lung transplantation using three different cytomegalovirus prophylactic regimens. Transplant Proc. 1993 Feb;25(1 Pt 2):1434–1435. [PubMed] [Google Scholar]\n\nMaurer JR, Tullis DE, Grossman RF, Vellend H, Winton TL, Patterson GA. Infectious complications following isolated lung transplantation. Chest. 1992 Apr;101(4):1056–1059. [PubMed] [Google Scholar]\n\nMayer JM, Nimer L, Carroll K. Isolated pulmonary aspergillar infection in cardiac transplant recipients: case report and review. Clin Infect Dis. 1992 Oct;15(4):698–700. [PubMed] [Google Scholar]\n\nMayers DL, Martone WJ, Mandell GL. Cutaneous cryptococcosis mimicking gram-positive cellulitis in a renal transplant patient. South Med J. 1981 Aug;74(8):1032–1033. [PubMed] [Google Scholar]\n\nMcAllister WA, Thompson PJ, Al-Habet SM, Rogers HJ. Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed) 1983 Mar 19;286(6369):923–925. [PMC free article] [PubMed] [Google Scholar]\n\nMcCarthy JM, McLoughlin MG, Shackleton CR, Cameron EC, Yeung CK, Jones EC, Keown PA. Cytomegalovirus epididymitis following renal transplantation. J Urol. 1991 Aug;146(2):417–419. [PubMed] [Google Scholar]\n\nMcCaughan GW, McDonald JA, Davies S, Painter DM. Clinicopathological approach to human liver allograft dysfunction. J Gastroenterol Hepatol. 1989 Sep-Oct;4(5):467–477. [PubMed] [Google Scholar]\n\nMcCormick WF, Schochet SS, Jr, Sarles HE, Calverley JR. Progressive multifocal leukoencephalopathy in renal transplant recipients. Arch Intern Med. 1976 Jul;136(7):829–834. [PubMed] [Google Scholar]\n\nMcDougall JC, Vigneswaran WT, Peters SG, Marshall WT, McGregor CG. Fungal infection of the contralateral native lung after single-lung transplantation. Ann Thorac Surg. 1993 Jul;56(1):176–178. [PubMed] [Google Scholar]\n\nMcGregor CG, Daly RC, Peters SG, Midthun DE, Scott JP, Allen MS, Tazelaar HD, Keating MR, Walker RC, McDougall JC. Evolving strategies in lung transplantation for emphysema. Ann Thorac Surg. 1994 Jun;57(6):1513–1521. [PubMed] [Google Scholar]\n\nMcGregor RS, Zitelli BJ, Urbach AH, Malatack JJ, Gartner JC., Jr Varicella in pediatric orthotopic liver transplant recipients. Pediatrics. 1989 Feb;83(2):256–261. [PubMed] [Google Scholar]\n\nMcLeish KR, McMurray SD, Smith EJ, Filo RS. The transmission of Candida albicans by cadaveric allografts. J Urol. 1977 Oct;118(4):513–516. [PubMed] [Google Scholar]\n\nMcNeil MM, Brown JM, Magruder CH, Shearlock KT, Saul RA, Allred DP, Ajello L. Disseminated Nocardia transvalensis infection: an unusual opportunistic pathogen in severely immunocompromised patients. J Infect Dis. 1992 Jan;165(1):175–178. [PubMed] [Google Scholar]\n\nMegison SM, Andrews WS. Combination therapy with ganciclovir and intravenous IgG for cytomegalovirus infections in pediatric liver transplant recipients. Transplantation. 1991 Jul;52(1):151–154. [PubMed] [Google Scholar]\n\nMerigan TC, Renlund DG, Keay S, Bristow MR, Starnes V, O'Connell JB, Resta S, Dunn D, Gamberg P, Ratkovec RM, et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med. 1992 Apr 30;326(18):1182–1186. [PubMed] [Google Scholar]\n\nMetselaar HJ, Balk AH, Mochtar B, Rothbarth PH, Weimar W. Cytomegalovirus seronegative heart transplant recipients. Prophylactic use of anti-CMV immunoglobulin. Chest. 1990 Feb;97(2):396–399. [PubMed] [Google Scholar]\n\nMetselaar HJ, Rothbarth PH, Brouwer RM, Wenting GJ, Jeekel J, Weimar W. Prevention of cytomegalovirus-related death by passive immunization. A double-blind placebo-controlled study in kidney transplant recipients treated for rejection. Transplantation. 1989 Aug;48(2):264–266. [PubMed] [Google Scholar]\n\nMezo A, Jennis F, McCarthy SW, Dawson DJ. Unusual mycobacteria in 5 cases of opportunistic infections. Pathology. 1979 Jul;11(3):377–384. [PubMed] [Google Scholar]\n\nMichaels MG, "
    }
}